[
    {
        "chrom":"chr1",
        "start_hg38":94418422,
        "stop_hg38":94418444,
        "start_hg19":94883978,
        "stop_hg19":94884000,
        "start_t2t":94266545,
        "stop_t2t":94266567,
        "notes_t2t":null,
        "id":"OPDM_ABCD3",
        "disease_id":"OPDM",
        "gene_strand":"+",
        "reference_motif_reference_orientation":"GCC",
        "pathogenic_motif_reference_orientation":"GCC",
        "pathogenic_motif_gene_orientation":"CCG",
        "benign_motif_reference_orientation":null,
        "benign_motif_gene_orientation":"",
        "unknown_motif_reference_orientation":null,
        "unknown_motif_gene_orientation":"",
        "disease":"Oculopharyngodistal myopathy",
        "gene":"ABCD3",
        "flank_motif":null,
        "locus_structure":"(GCC)*",
        "Inheritance":"AD",
        "type":"5' UTR",
        "location_in_gene":null,
        "normal":"3-44",
        "normal_min":3.0,
        "normal_max":44.0,
        "intermediate":null,
        "intermediate_min":null,
        "intermediate_max":null,
        "pathogenic":"118-694",
        "pathogenic_min":118.0,
        "pathogenic_max":694.0,
        "ref_copies":7.7,
        "repeatunitlen":3,
        "age_onset":"Typical: 24-30; Range: 10-50 (doi.org\/10.1101\/2023.10.09.23296582)",
        "age_onset_min":10,
        "age_onset_max":50,
        "typ_age_onset_min":null,
        "typ_age_onset_max":null,
        "novel":null,
        "Mechanism":null,
        "Mechanism_detail":null,
        "Mechanism_source":null,
        "source":"https:\/\/doi.org\/10.1101\/2023.10.09.23296582",
        "notes":null,
        "details":null,
        "width":null,
        "OMIM":null,
        "Prevalence":null,
        "Prevalence_details":"Unknown",
        "STRipy_gene":null,
        "gnomAD_gene":null,
        "GeneReviews":null,
        "Year":2023.0
    },
    {
        "chrom":"chrX",
        "start_hg38":148500605,
        "stop_hg38":148500753,
        "start_hg19":147582125,
        "stop_hg19":147582273,
        "start_t2t":146765191,
        "stop_t2t":146765342,
        "notes_t2t":"(GCC)51.3",
        "id":"FRAXE_AFF2",
        "disease_id":"FRAXE",
        "gene_strand":"+",
        "reference_motif_reference_orientation":"GCC",
        "pathogenic_motif_reference_orientation":"GCC",
        "pathogenic_motif_gene_orientation":"CCG",
        "benign_motif_reference_orientation":null,
        "benign_motif_gene_orientation":"",
        "unknown_motif_reference_orientation":null,
        "unknown_motif_gene_orientation":"",
        "disease":"Fragile X syndrome, FRAXE type",
        "gene":"AFF2",
        "flank_motif":null,
        "locus_structure":"(GCC)*",
        "Inheritance":"XR",
        "type":"5' UTR",
        "location_in_gene":"5\u2019 Region",
        "normal":"4-39",
        "normal_min":4.0,
        "normal_max":39.0,
        "intermediate":null,
        "intermediate_min":null,
        "intermediate_max":null,
        "pathogenic":"200-2000",
        "pathogenic_min":200.0,
        "pathogenic_max":2000.0,
        "ref_copies":50.3,
        "repeatunitlen":3,
        "age_onset":"Typical: 2-10; Range: 1-10 (developmental delays without physical features can make onset difficult to detect until schooling)",
        "age_onset_min":1,
        "age_onset_max":10,
        "typ_age_onset_min":2.0,
        "typ_age_onset_max":10.0,
        "novel":"ref",
        "Mechanism":"LOF, reduced gene expression",
        "Mechanism_detail":"Loss of function via transcriptional silencing",
        "Mechanism_source":"(doi.org\/10.1038\/nrg1691) (doi.org\/10.1007\/s11604-022-01343-5)",
        "source":"Mirkin 2007, OMIM, GeneReviews NBK535148",
        "notes":null,
        "details":null,
        "width":148.0,
        "OMIM":"309548",
        "Prevalence":"2\/50000",
        "Prevalence_details":"1-4\/100,000 males (https:\/\/medlineplus.gov\/genetics\/condition\/fragile-xe-syndrome); 1\/50-100,000 males, more than 50 families (PMID: 11246464)",
        "STRipy_gene":"AFF2",
        "gnomAD_gene":"AFF2",
        "GeneReviews":"NBK535148",
        "Year":1993.0
    },
    {
        "chrom":"chr2",
        "start_hg38":100104799,
        "stop_hg38":100104824,
        "start_hg19":100721261,
        "stop_hg19":100721286,
        "start_t2t":100563686,
        "stop_t2t":100563738,
        "notes_t2t":"(GCC)17.7",
        "id":"FRA2A_AFF3",
        "disease_id":"FRA2A",
        "gene_strand":"-",
        "reference_motif_reference_orientation":"GCC",
        "pathogenic_motif_reference_orientation":"GCC",
        "pathogenic_motif_gene_orientation":"CGG",
        "benign_motif_reference_orientation":null,
        "benign_motif_gene_orientation":"",
        "unknown_motif_reference_orientation":null,
        "unknown_motif_gene_orientation":"",
        "disease":"Intellectual disability associated with fragile site FRA2A",
        "gene":"AFF3",
        "flank_motif":null,
        "locus_structure":"(GCC)*",
        "Inheritance":"AD",
        "type":"Intronic",
        "location_in_gene":"Intron ",
        "normal":"3-20",
        "normal_min":3.0,
        "normal_max":20.0,
        "intermediate":null,
        "intermediate_min":null,
        "intermediate_max":null,
        "pathogenic":"300",
        "pathogenic_min":300.0,
        "pathogenic_max":300.0,
        "ref_copies":8.7,
        "repeatunitlen":3,
        "age_onset":"Early childhood (small sample size) (PMID: 24763282)",
        "age_onset_min":1,
        "age_onset_max":7,
        "typ_age_onset_min":null,
        "typ_age_onset_max":null,
        "novel":"ref",
        "Mechanism":"Decreased gene expression, methylation",
        "Mechanism_detail":"\"silencing of the FMR2 gene as a consequence of a CCG expansion located upstream of this gene\"",
        "Mechanism_source":"malacard",
        "source":"https:\/\/doi.org\/10.1038\/s41580-021-00382-6, PMC3998887",
        "notes":"Path threshold may actually be higher than 300, assay was not sensitive enough",
        "details":null,
        "width":25.0,
        "OMIM":"601464",
        "Prevalence":null,
        "Prevalence_details":"1\/862 (1\/654-1266) population prevalence of methylated AFF3 expansions (mild cognitive disability) https:\/\/www.medrxiv.org\/content\/10.1101\/2023.05.03.23289461v1.full.pdf",
        "STRipy_gene":null,
        "gnomAD_gene":null,
        "GeneReviews":null,
        "Year":2014.0
    },
    {
        "chrom":"chrX",
        "start_hg38":67545317,
        "stop_hg38":67545419,
        "start_hg19":66765159,
        "stop_hg19":66765261,
        "start_t2t":65975148,
        "stop_t2t":65975250,
        "notes_t2t":"(GCA)33.3",
        "id":"SBMA_AR",
        "disease_id":"SBMA",
        "gene_strand":"+",
        "reference_motif_reference_orientation":"GCA",
        "pathogenic_motif_reference_orientation":"GCA",
        "pathogenic_motif_gene_orientation":"AGC",
        "benign_motif_reference_orientation":null,
        "benign_motif_gene_orientation":"",
        "unknown_motif_reference_orientation":null,
        "unknown_motif_gene_orientation":"",
        "disease":"Spinal and bulbar muscular atrophy, Kennedy Disease",
        "gene":"AR",
        "flank_motif":null,
        "locus_structure":"(GCA)*",
        "Inheritance":"XR",
        "type":"Coding",
        "location_in_gene":"Exon 1",
        "normal":"9\u201334",
        "normal_min":9.0,
        "normal_max":34.0,
        "intermediate":"36-37",
        "intermediate_min":36.0,
        "intermediate_max":37.0,
        "pathogenic":"38\u201368",
        "pathogenic_min":38.0,
        "pathogenic_max":68.0,
        "ref_copies":34.0,
        "repeatunitlen":3,
        "age_onset":"Typical: 20-49 (OMIM), Range: 15-75 (https:\/\/doi.org\/10.1038\/sj.ejhg.5200656) ",
        "age_onset_min":15,
        "age_onset_max":75,
        "typ_age_onset_min":20.0,
        "typ_age_onset_max":49.0,
        "novel":"ref",
        "Mechanism":"Polyglutamine",
        "Mechanism_detail":"Polyglutamine",
        "Mechanism_source":"(doi.org\/10.1038\/nrg.2017.115) (doi.org\/10.1007\/s11604-022-01343-5)",
        "source":"Hannan 2018, Mirkin 2007, GeneReviews NBK535148, s40478-021-01201-x",
        "notes":"Can have 'CAA' as an interruption (PMID: 35245110)",
        "details":null,
        "width":102.0,
        "OMIM":"313200",
        "Prevalence":"1\/30000",
        "Prevalence_details":"1-2\/100,000 (population-specific, higher in Finnish population, Canadian population) (PMID: 37628685); 1\/30,000  (Orphanet) ; mutation frequency of 1:3182 10x more frequent than reported disease prevalence of 1 in 30,000 (PMID: 36797998); Tang et al., 2017: 0.67-2.5\/100,000",
        "STRipy_gene":"AR",
        "gnomAD_gene":"AR",
        "GeneReviews":"NBK1333",
        "Year":1991.0
    },
    {
        "chrom":"chrX",
        "start_hg38":25013649,
        "stop_hg38":25013697,
        "start_hg19":25031766,
        "stop_hg19":25031814,
        "start_t2t":24597886,
        "stop_t2t":24597934,
        "notes_t2t":"(GCC)14.7",
        "id":"EIEE1_ARX",
        "disease_id":"EIEE1",
        "gene_strand":"-",
        "reference_motif_reference_orientation":"NGC",
        "pathogenic_motif_reference_orientation":"NGC",
        "pathogenic_motif_gene_orientation":"CNG",
        "benign_motif_reference_orientation":null,
        "benign_motif_gene_orientation":"",
        "unknown_motif_reference_orientation":null,
        "unknown_motif_gene_orientation":"",
        "disease":"Early-infantile epileptic encephalopathy",
        "gene":"ARX",
        "flank_motif":null,
        "locus_structure":"(NGC)*",
        "Inheritance":"XR",
        "type":"Coding",
        "location_in_gene":"Exon 2",
        "normal":"10-16",
        "normal_min":10.0,
        "normal_max":16.0,
        "intermediate":null,
        "intermediate_min":null,
        "intermediate_max":null,
        "pathogenic":"17-27",
        "pathogenic_min":17.0,
        "pathogenic_max":27.0,
        "ref_copies":14.7,
        "repeatunitlen":3,
        "age_onset":"Typical: 0 (PMID: 21204215, PMID: 9307258, OMIM); Range: 0-4 (Childhood epilepsy, cognitive disability,  \u223c70% of cases infantile spasms -->  seizures by 3 or 4 years re: PMID: 19587282)",
        "age_onset_min":0,
        "age_onset_max":4,
        "typ_age_onset_min":0.0,
        "typ_age_onset_max":0.0,
        "novel":"ref",
        "Mechanism":"Polyalanine",
        "Mechanism_detail":"Polyalanine",
        "Mechanism_source":"(doi.org\/10.1038\/nature05977) (doi.org\/10.1007\/s11604-022-01343-5)",
        "source":"GeneReviews NBK535148, OMIM",
        "notes":"Exon 2 aa 110-115",
        "details":null,
        "width":43.0,
        "OMIM":"308350; 300419; 300215",
        "Prevalence":null,
        "Prevalence_details":"Unknown",
        "STRipy_gene":"ARX_1",
        "gnomAD_gene":"ARX_1",
        "GeneReviews":"NBK535148",
        "Year":null
    },
    {
        "chrom":"chrX",
        "start_hg38":25013530,
        "stop_hg38":25013565,
        "start_hg19":25031647,
        "stop_hg19":25031682,
        "start_t2t":24597767,
        "stop_t2t":24597799,
        "notes_t2t":"(GGCCGCGGCGGCCGC)2.2",
        "id":"PRTS_ARX",
        "disease_id":"PRTS",
        "gene_strand":"-",
        "reference_motif_reference_orientation":"NGC",
        "pathogenic_motif_reference_orientation":"NGC",
        "pathogenic_motif_gene_orientation":"CNG",
        "benign_motif_reference_orientation":null,
        "benign_motif_gene_orientation":"",
        "unknown_motif_reference_orientation":null,
        "unknown_motif_gene_orientation":"",
        "disease":"Partington syndrome",
        "gene":"ARX",
        "flank_motif":null,
        "locus_structure":"(NGC)*",
        "Inheritance":"XR",
        "type":"Coding",
        "location_in_gene":"Exon 2",
        "normal":"12",
        "normal_min":12.0,
        "normal_max":12.0,
        "intermediate":null,
        "intermediate_min":null,
        "intermediate_max":null,
        "pathogenic":"20",
        "pathogenic_min":20.0,
        "pathogenic_max":20.0,
        "ref_copies":12.0,
        "repeatunitlen":3,
        "age_onset":"Typical: 1-3; Range: 0-4 (OMIM); Mildness can make diagnosis difficult (particularly mild\/absent in females) ",
        "age_onset_min":0,
        "age_onset_max":4,
        "typ_age_onset_min":null,
        "typ_age_onset_max":null,
        "novel":"ref",
        "Mechanism":"Polyalanine",
        "Mechanism_detail":"Polyalanine",
        "Mechanism_source":"(OMIM) (doi.org\/10.1007\/s11604-022-01343-5)",
        "source":"GeneReviews NBK535148, OMIM",
        "notes":"Novel, Exon 2 aa 144-155",
        "details":null,
        "width":35.0,
        "OMIM":"309510",
        "Prevalence":null,
        "Prevalence_details":"Unknown",
        "STRipy_gene":"ARX_2",
        "gnomAD_gene":"ARX_2",
        "GeneReviews":"NBK535148",
        "Year":null
    },
    {
        "chrom":"chr12",
        "start_hg38":6936717,
        "stop_hg38":6936775,
        "start_hg19":7045880,
        "stop_hg19":7045938,
        "start_t2t":6947904,
        "stop_t2t":6947941,
        "notes_t2t":"(CAG)12.7",
        "id":"DRPLA_ATN1",
        "disease_id":"DRPLA",
        "gene_strand":"+",
        "reference_motif_reference_orientation":"CAG",
        "pathogenic_motif_reference_orientation":"CAG",
        "pathogenic_motif_gene_orientation":"AGC",
        "benign_motif_reference_orientation":null,
        "benign_motif_gene_orientation":"",
        "unknown_motif_reference_orientation":null,
        "unknown_motif_gene_orientation":"",
        "disease":"Dentatorubral-Pallidoluysian Atrophy",
        "gene":"ATN1",
        "flank_motif":null,
        "locus_structure":"(CAG)*",
        "Inheritance":"AD",
        "type":"Coding",
        "location_in_gene":"Exon 5",
        "normal":"3\u201335",
        "normal_min":3.0,
        "normal_max":35.0,
        "intermediate":null,
        "intermediate_min":null,
        "intermediate_max":null,
        "pathogenic":"48-93",
        "pathogenic_min":48.0,
        "pathogenic_max":93.0,
        "ref_copies":19.0,
        "repeatunitlen":3,
        "age_onset":"Typical: 20-40 (PMID: 6808417, NBK1491); Range: 0 (PMID: 11160976) - 72 (NBK1491)",
        "age_onset_min":0,
        "age_onset_max":72,
        "typ_age_onset_min":20.0,
        "typ_age_onset_max":40.0,
        "novel":"ref",
        "Mechanism":"Polyglutamine",
        "Mechanism_detail":"Polyglutamine",
        "Mechanism_source":"(doi.org\/10.1038\/nrg.2017.115) (doi.org\/10.1007\/s11604-022-01343-5)",
        "source":"Hannan 2018, Mirkin 2007, GeneReviews NBK535148, s40478-021-01201-x",
        "notes":"Interruptions: CAA (PMID: 35245110)",
        "details":null,
        "width":58.0,
        "OMIM":"125370",
        "Prevalence":"4.5\/1000000",
        "Prevalence_details":"2-7\/1,000,000",
        "STRipy_gene":"ATN1",
        "gnomAD_gene":"ATN1",
        "GeneReviews":"NBK1491",
        "Year":1994.0
    },
    {
        "chrom":"chr6",
        "start_hg38":16327634,
        "stop_hg38":16327724,
        "start_hg19":16327865,
        "stop_hg19":16327955,
        "start_t2t":16200189,
        "stop_t2t":16200282,
        "notes_t2t":"(TGC)31.1",
        "id":"SCA1_ATXN1",
        "disease_id":"SCA1",
        "gene_strand":"-",
        "reference_motif_reference_orientation":"CTG",
        "pathogenic_motif_reference_orientation":"CTG",
        "pathogenic_motif_gene_orientation":"AGC",
        "benign_motif_reference_orientation":null,
        "benign_motif_gene_orientation":"",
        "unknown_motif_reference_orientation":null,
        "unknown_motif_gene_orientation":"",
        "disease":"Spinocerebellar Ataxia Type 1",
        "gene":"ATXN1",
        "flank_motif":null,
        "locus_structure":"(CTG)*",
        "Inheritance":"AD",
        "type":"Coding",
        "location_in_gene":"Exon 8",
        "normal":"6\u201335",
        "normal_min":6.0,
        "normal_max":35.0,
        "intermediate":"36-38",
        "intermediate_min":36.0,
        "intermediate_max":38.0,
        "pathogenic":"39\u201391",
        "pathogenic_min":39.0,
        "pathogenic_max":91.0,
        "ref_copies":30.3,
        "repeatunitlen":3,
        "age_onset":"Typical: 20-39 (UptoDate); Range: 6(PMID: 3165612)-63 (PMID: 8825276)",
        "age_onset_min":6,
        "age_onset_max":63,
        "typ_age_onset_min":20.0,
        "typ_age_onset_max":39.0,
        "novel":"ref",
        "Mechanism":"Polyglutamine",
        "Mechanism_detail":"Polyglutamine",
        "Mechanism_source":"(doi.org\/10.1038\/nrg.2017.115) (doi.org\/10.1007\/s11604-022-01343-5)",
        "source":"Hannan 2018, Mirkin 2007, GeneReviews NBK1184, s40478-021-01201-x",
        "notes":"Interruptions: CAT (PMID: 35245110)",
        "details":null,
        "width":90.0,
        "OMIM":"164400",
        "Prevalence":"1.5\/100000",
        "Prevalence_details":"1-2\/100,000",
        "STRipy_gene":"ATXN1",
        "gnomAD_gene":"ATXN1",
        "GeneReviews":"NBK1184",
        "Year":1993.0
    },
    {
        "chrom":"chr22",
        "start_hg38":45795355,
        "stop_hg38":45795424,
        "start_hg19":46191235,
        "stop_hg19":46191304,
        "start_t2t":46280060,
        "stop_t2t":46280129,
        "notes_t2t":"(ATTCT)15.0",
        "id":"SCA10_ATXN10",
        "disease_id":"SCA10",
        "gene_strand":"+",
        "reference_motif_reference_orientation":"ATTCT",
        "pathogenic_motif_reference_orientation":"ATTCT",
        "pathogenic_motif_gene_orientation":"ATTCT",
        "benign_motif_reference_orientation":null,
        "benign_motif_gene_orientation":"",
        "unknown_motif_reference_orientation":null,
        "unknown_motif_gene_orientation":"",
        "disease":"Spinocerebellar Ataxia Type 10",
        "gene":"ATXN10",
        "flank_motif":null,
        "locus_structure":"(ATTCT)*",
        "Inheritance":"AD",
        "type":"Intronic",
        "location_in_gene":"Intron 9\/11",
        "normal":"10\u201332",
        "normal_min":10.0,
        "normal_max":32.0,
        "intermediate":"280-850",
        "intermediate_min":280.0,
        "intermediate_max":850.0,
        "pathogenic":"800-4500",
        "pathogenic_min":800.0,
        "pathogenic_max":4500.0,
        "ref_copies":14.0,
        "repeatunitlen":5,
        "age_onset":"Typical: 12-48; Range: 11-83 (NBK1175)",
        "age_onset_min":11,
        "age_onset_max":83,
        "typ_age_onset_min":12.0,
        "typ_age_onset_max":48.0,
        "novel":"ref",
        "Mechanism":"GOF (RNA)",
        "Mechanism_detail":"Transdominant mechanism theorized",
        "Mechanism_source":"(malacard), PMID: 38467784",
        "source":"Hannan 2018, Mirkin 2007, GeneReviews NBK535148, s40478-021-01201-x",
        "notes":"SCA10 expansions are frequently interrupted by ATCCT, ATCCC, ATTCC, ATTTCT, ATATTCT, ATTCTTCT, or ATTCTTCT; also interruptions of ATTGT, TTTCT, ATTTTCT, ATTCTCT (PMID: 36199580). Additional interruption ATGCT (PMID: 19234597). ATCCT interruption motif is associated with a higher prevalence of epileptic seizures [McFarland et al 2014].",
        "details":null,
        "width":69.0,
        "OMIM":"603516",
        "Prevalence":null,
        "Prevalence_details":"Unknown; >300 individuals (GeneReview)",
        "STRipy_gene":"ATXN10",
        "gnomAD_gene":"ATXN10",
        "GeneReviews":null,
        "Year":2000.0
    },
    {
        "chrom":"chr12",
        "start_hg38":111598950,
        "stop_hg38":111599019,
        "start_hg19":112036754,
        "stop_hg19":112036823,
        "start_t2t":111575873,
        "stop_t2t":111575940,
        "notes_t2t":"(GCT)22.3",
        "id":"SCA2_ATXN2",
        "disease_id":"SCA2",
        "gene_strand":"-",
        "reference_motif_reference_orientation":"CTG",
        "pathogenic_motif_reference_orientation":"CTG",
        "pathogenic_motif_gene_orientation":"AGC",
        "benign_motif_reference_orientation":null,
        "benign_motif_gene_orientation":"",
        "unknown_motif_reference_orientation":null,
        "unknown_motif_gene_orientation":"",
        "disease":"Spinocerebellar Ataxia Type 2",
        "gene":"ATXN2",
        "flank_motif":null,
        "locus_structure":"(CTG)*",
        "Inheritance":"AD\/AR",
        "type":"Coding",
        "location_in_gene":"Exon 1",
        "normal":"14\u201331",
        "normal_min":14.0,
        "normal_max":31.0,
        "intermediate":"32-34",
        "intermediate_min":32.0,
        "intermediate_max":34.0,
        "pathogenic":"33\u2013200",
        "pathogenic_min":33.0,
        "pathogenic_max":200.0,
        "ref_copies":23.3,
        "repeatunitlen":3,
        "age_onset":"Typical: 30-39 (GeneReview); Range: 2-86 (OMIM)",
        "age_onset_min":2,
        "age_onset_max":86,
        "typ_age_onset_min":30.0,
        "typ_age_onset_max":39.0,
        "novel":"ref",
        "Mechanism":"Polyglutamine ",
        "Mechanism_detail":"Polyglutamine ",
        "Mechanism_source":"(doi.org\/10.1038\/nrg.2017.115) (doi.org\/10.1007\/s11604-022-01343-5)",
        "source":"Hannan 2018, GeneReviews NBK1275, s40478-021-01201-x",
        "notes":"29\u201332 repeats: increased ALS risk, Interruptions: CAA, CGG, CGC. Parkinson disease, late-onset, susceptibility.",
        "details":null,
        "width":69.0,
        "OMIM":"183090",
        "Prevalence":"1.5\/100000",
        "Prevalence_details":"1-2\/100,000 (Tang et al., 2017) (population dependent)",
        "STRipy_gene":"ATXN2",
        "gnomAD_gene":"ATXN2",
        "GeneReviews":"NBK1275",
        "Year":1996.0
    },
    {
        "chrom":"chr14",
        "start_hg38":92071012,
        "stop_hg38":92071053,
        "start_hg19":92537356,
        "stop_hg19":92537397,
        "start_t2t":86300520,
        "stop_t2t":86300603,
        "notes_t2t":"(CTG)28.0",
        "id":"SCA3_ATXN3",
        "disease_id":"SCA3, MJD",
        "gene_strand":"-",
        "reference_motif_reference_orientation":"CTG",
        "pathogenic_motif_reference_orientation":"CTG",
        "pathogenic_motif_gene_orientation":"AGC",
        "benign_motif_reference_orientation":null,
        "benign_motif_gene_orientation":"",
        "unknown_motif_reference_orientation":null,
        "unknown_motif_gene_orientation":"",
        "disease":"Spinocerebellar Ataxia Type 3\/Machado-Joseph Disease",
        "gene":"ATXN3",
        "flank_motif":null,
        "locus_structure":"(CTG)*",
        "Inheritance":"AD",
        "type":"Coding",
        "location_in_gene":"Second last exon",
        "normal":"12\u201344",
        "normal_min":12.0,
        "normal_max":44.0,
        "intermediate":"45-59",
        "intermediate_min":45.0,
        "intermediate_max":59.0,
        "pathogenic":"60-87",
        "pathogenic_min":60.0,
        "pathogenic_max":87.0,
        "ref_copies":14.0,
        "repeatunitlen":3,
        "age_onset":"Typical: 10-49 (GeneReview); 5-73 (GeneReview; PMID: 30414314)",
        "age_onset_min":5,
        "age_onset_max":73,
        "typ_age_onset_min":10.0,
        "typ_age_onset_max":49.0,
        "novel":"ref",
        "Mechanism":"Polyglutamine ",
        "Mechanism_detail":"Polyglutamine ",
        "Mechanism_source":"(doi.org\/10.1038\/nrg.2017.115) (doi.org\/10.1007\/s11604-022-01343-5)",
        "source":"Hannan 2018, Mirkin 2007, GeneReviews NBK535148, s40478-021-01201-x",
        "notes":"Interruptions: CAA (PMID: 35245110); AAG is present in hg38 reference sequence",
        "details":null,
        "width":41.0,
        "OMIM":"109150",
        "Prevalence":"2.1\/100000",
        "Prevalence_details":"1\u20135\/100,000, Tang et al., 2017; Most prevalence SCA subtype (NBK557816)",
        "STRipy_gene":"ATXN3",
        "gnomAD_gene":"ATXN3",
        "GeneReviews":"NBK1196",
        "Year":1994.0
    },
    {
        "chrom":"chr3",
        "start_hg38":63912685,
        "stop_hg38":63912716,
        "start_hg19":63898361,
        "stop_hg19":63898392,
        "start_t2t":63956303,
        "stop_t2t":63956334,
        "notes_t2t":"(GCA)10.7",
        "id":"SCA7_ATXN7",
        "disease_id":"SCA7",
        "gene_strand":"+",
        "reference_motif_reference_orientation":"CAG",
        "pathogenic_motif_reference_orientation":"CAG",
        "pathogenic_motif_gene_orientation":"AGC",
        "benign_motif_reference_orientation":null,
        "benign_motif_gene_orientation":"",
        "unknown_motif_reference_orientation":null,
        "unknown_motif_gene_orientation":"",
        "disease":"Spinocerebellar Ataxia Type 7",
        "gene":"ATXN7",
        "flank_motif":"(CAG)n(CCG)4",
        "locus_structure":"(CAG)*(CCG)+",
        "Inheritance":"AD",
        "type":"Coding",
        "location_in_gene":"Exon 1, 2, or 3 (depending on isoform)",
        "normal":"4\u201319",
        "normal_min":4.0,
        "normal_max":19.0,
        "intermediate":"28-35",
        "intermediate_min":28.0,
        "intermediate_max":35.0,
        "pathogenic":"34\u2013460",
        "pathogenic_min":34.0,
        "pathogenic_max":460.0,
        "ref_copies":10.7,
        "repeatunitlen":3,
        "age_onset":"Typical: 4-48 (PMID: 20739808); Range: 0-65 (GeneReview)",
        "age_onset_min":0,
        "age_onset_max":65,
        "typ_age_onset_min":4.0,
        "typ_age_onset_max":48.0,
        "novel":"ref",
        "Mechanism":"Polyglutamine ",
        "Mechanism_detail":"Polyglutamine ",
        "Mechanism_source":"(doi.org\/10.1038\/nrg.2017.115) (doi.org\/10.1007\/s11604-022-01343-5)",
        "source":"Hannan 2018, Mirkin 2007, GeneReviews NBK535148, s40478-021-01201-x",
        "notes":"Interruptions: CAA (PMID: 35245110)",
        "details":null,
        "width":31.0,
        "OMIM":"164500",
        "Prevalence":".999\/300000",
        "Prevalence_details":"<1\/300,000 (GeneReview)",
        "STRipy_gene":"ATXN7",
        "gnomAD_gene":"ATXN7",
        "GeneReviews":"NBK1256",
        "Year":1996.0
    },
    {
        "chrom":"chr13",
        "start_hg38":70139383,
        "stop_hg38":70139429,
        "start_hg19":70713515,
        "stop_hg19":70713561,
        "start_t2t":69361244,
        "stop_t2t":69361271,
        "notes_t2t":"(CTG)9.3",
        "id":"SCA8_ATXN8OS",
        "disease_id":"SCA8",
        "gene_strand":"+",
        "reference_motif_reference_orientation":"CTG",
        "pathogenic_motif_reference_orientation":"CTG",
        "pathogenic_motif_gene_orientation":"CTG",
        "benign_motif_reference_orientation":null,
        "benign_motif_gene_orientation":"",
        "unknown_motif_reference_orientation":null,
        "unknown_motif_gene_orientation":"",
        "disease":"Spinocerebellar Ataxia Type 8",
        "gene":"ATXN8OS",
        "flank_motif":"(CTA)10(CTG)n",
        "locus_structure":"(CTA)*(CTG)*",
        "Inheritance":"AD",
        "type":"3' UTR",
        "location_in_gene":"Exon 5 or 3\u2019 UTR depending on transcript",
        "normal":"15\u201350",
        "normal_min":15.0,
        "normal_max":50.0,
        "intermediate":"50-70",
        "intermediate_min":50.0,
        "intermediate_max":70.0,
        "pathogenic":"71-1300",
        "pathogenic_min":71.0,
        "pathogenic_max":1300.0,
        "ref_copies":15.3,
        "repeatunitlen":3,
        "age_onset":"Typical: 20-40; Range: 0-73 (GeneReview)",
        "age_onset_min":1,
        "age_onset_max":73,
        "typ_age_onset_min":20.0,
        "typ_age_onset_max":49.0,
        "novel":"ref",
        "Mechanism":"Polyglutamine\/toxic gain-of-function; Unknown ",
        "Mechanism_detail":"Polyglutamine\/toxic gain-of-function; Unknown ",
        "Mechanism_source":"(OMIM) (doi.org\/10.1007\/s11604-022-01343-5)",
        "source":"Hannan 2018, Mirkin 2007, GeneReviews NBK535148, s40478-021-01201-x",
        "notes":"Two genes span the CTG\/CAG repeat and are expressed in opposite directions: ATXN8, which encodes a nearly pure polyglutamine expansion protein in the CAG direction, and ATXN8OS (603680), which, when transcribed, produces a noncoding CUG expansion RNA (Moseley et al., 2006). Roda et al. suggested that the ATXN8 or ATXN8OS gene should not be evaluated in isolation as a candidate gene for spinocerebellar degenerative disease. CCG•CGG interruptions in high‐penetrance SCA8 families increase RAN translation and protein toxicity (PMID: 34632710); 'Interruptions w/in CTG·CAG expansion by 1 or more CCG·CGG, CTA·TAG, CTC·GAG, CCA·TGG, or CTT·AAG trinucleotides have been observed in full-penetrance repeats [Moseley et al 2006; Authors, unpublished data].' (GeneReviews)",
        "details":null,
        "width":46.0,
        "OMIM":"608768",
        "Prevalence":"0.5\/100000",
        "Prevalence_details":"<1\/100,000; Tang et al., 2017; Expansion in 1:100-1200 chromosomes (GeneReview)",
        "STRipy_gene":"ATXN8OS",
        "gnomAD_gene":"ATXN8OS",
        "GeneReviews":"NBK1268",
        "Year":1999.0
    },
    {
        "chrom":"chr16",
        "start_hg38":66490397,
        "stop_hg38":66490466,
        "start_hg19":66524300,
        "stop_hg19":66524369,
        "start_t2t":72284667,
        "stop_t2t":72284761,
        "notes_t2t":"(AATAA)19.4",
        "id":"SCA31_BEAN1",
        "disease_id":"SCA31",
        "gene_strand":"+",
        "reference_motif_reference_orientation":"AATAA",
        "pathogenic_motif_reference_orientation":"TGGAA,TAGAA",
        "pathogenic_motif_gene_orientation":"AATGG,AATAG",
        "benign_motif_reference_orientation":null,
        "benign_motif_gene_orientation":"",
        "unknown_motif_reference_orientation":"AAAAA,AAAAC,AAATG,AGAAA,ATAAG,TAAAC,TAACA,TACAA,TCAAA,TGCAA",
        "unknown_motif_gene_orientation":"AAAAA,AAAAC,AAATG,AAAAG,AAGAT,AAACT,AACAT,AATAC,AAATC,AATGC",
        "disease":"Spinocerebellar Ataxia Type 31",
        "gene":"BEAN1",
        "flank_motif":null,
        "locus_structure":"(TGGAA)*(TAGAA)*",
        "Inheritance":"AD",
        "type":"Intronic",
        "location_in_gene":"Intron 4\/4",
        "normal":"0-10",
        "normal_min":0.0,
        "normal_max":10.0,
        "intermediate":null,
        "intermediate_min":null,
        "intermediate_max":null,
        "pathogenic":">110",
        "pathogenic_min":110.0,
        "pathogenic_max":760.0,
        "ref_copies":14.4,
        "repeatunitlen":5,
        "age_onset":"Typical: 56-62 (PMID: 36563608); Range: 8-83 (PMID: 23331413) ",
        "age_onset_min":8,
        "age_onset_max":83,
        "typ_age_onset_min":56.0,
        "typ_age_onset_max":62.0,
        "novel":"novel",
        "Mechanism":"Epigenetic",
        "Mechanism_detail":"Role in heterochromatin or chromosomal structure theorized ",
        "Mechanism_source":"(OMIM)",
        "source":"OMIM, Sato 2009, 19878914 (Pubmed), https:\/\/doi.org\/10.1038\/s41580-021-00382-6",
        "notes":"Novel, STR-containing insertion, not present in reference genome: Reds disagree on normal\/pathogenic sizes",
        "details":null,
        "width":69.0,
        "OMIM":"117210",
        "Prevalence":null,
        "Prevalence_details":"Unknown (more common in Japanese pop)",
        "STRipy_gene":"BEAN1",
        "gnomAD_gene":"BEAN1",
        "GeneReviews":"NBK535148",
        "Year":2009.0
    },
    {
        "chrom":"chr9",
        "start_hg38":27573484,
        "stop_hg38":27573546,
        "start_hg19":27573482,
        "stop_hg19":27573544,
        "start_t2t":27584063,
        "stop_t2t":27584155,
        "notes_t2t":"(GCCCCG)15.8",
        "id":"FTDALS1_C9orf72",
        "disease_id":"FTDALS1",
        "gene_strand":"-",
        "reference_motif_reference_orientation":"GGCCCC",
        "pathogenic_motif_reference_orientation":"GGCCCC",
        "pathogenic_motif_gene_orientation":"CCGGGG",
        "benign_motif_reference_orientation":null,
        "benign_motif_gene_orientation":"",
        "unknown_motif_reference_orientation":null,
        "unknown_motif_gene_orientation":"",
        "disease":"Frontotemporal dementia (FTD) and\/or amyotrophic lateral sclerosis (ALS)",
        "gene":"C9orf72",
        "flank_motif":null,
        "locus_structure":"(GGCCCC)*",
        "Inheritance":"AD",
        "type":"Intronic",
        "location_in_gene":"Intron 1 or 5' depending on transcript",
        "normal":"3\u201325 (2-19 Reds)",
        "normal_min":2.0,
        "normal_max":20.0,
        "intermediate":"20-60",
        "intermediate_min":20.0,
        "intermediate_max":60.0,
        "pathogenic":"250-2000",
        "pathogenic_min":250.0,
        "pathogenic_max":2000.0,
        "ref_copies":10.8,
        "repeatunitlen":6,
        "age_onset":"Typical: 50-64; Range: 20-91 (GeneReview)",
        "age_onset_min":20,
        "age_onset_max":91,
        "typ_age_onset_min":50.0,
        "typ_age_onset_max":64.0,
        "novel":"ref",
        "Mechanism":"RNA toxicity proposed",
        "Mechanism_detail":"\"The HRE forms DNA and RNA G-quadruplexes with distinct structures and promotes RNA\/DNA hybrids (R-loops). The structural polymorphism causes a repeat length-dependent accumulation of transcripts aborted in the HRE region.\"",
        "Mechanism_source":"OMIM",
        "source":"Hannan 2018, GeneReviews NBK535148, OMIM, s40478-021-01201-x",
        "notes":"Pathogenic lower range is controversial. (STRipy)",
        "details":null,
        "width":62.0,
        "OMIM":"105500",
        "Prevalence":null,
        "Prevalence_details":"The expansion of a hexanucleotide repeat GGGGCC in C9orf72 is the most common known cause of ALS accounting for ~ 40% familial cases and ~ 7% sporadic cases in the European population; overall ALS incidence is 1-2\/100,000 person-years, point prevalence is 3-5\/100,000 (Europe\/US); lifetime risk is 1 in 300 (PMID: 31315673). C9orf72-FTD is estimated to be 0.04-134:100,000 (GeneReview), and by our estimates 0.65-1.56\/100,000 for C9orf72-ALS. ",
        "STRipy_gene":"C9ORF72",
        "gnomAD_gene":"C9ORF72",
        "GeneReviews":"NBK268647",
        "Year":2011.0
    },
    {
        "chrom":"chr19",
        "start_hg38":13207859,
        "stop_hg38":13207898,
        "start_hg19":13318673,
        "stop_hg19":13318712,
        "start_t2t":13333137,
        "stop_t2t":13333176,
        "notes_t2t":"(CTG)13.3",
        "id":"SCA6_CACNA1A",
        "disease_id":"SCA6",
        "gene_strand":"-",
        "reference_motif_reference_orientation":"CTG",
        "pathogenic_motif_reference_orientation":"CTG",
        "pathogenic_motif_gene_orientation":"AGC",
        "benign_motif_reference_orientation":null,
        "benign_motif_gene_orientation":"",
        "unknown_motif_reference_orientation":null,
        "unknown_motif_gene_orientation":"",
        "disease":"Spinocerebellar Ataxia Type 6",
        "gene":"CACNA1A",
        "flank_motif":null,
        "locus_structure":"(CTG)*",
        "Inheritance":"AD",
        "type":"Coding",
        "location_in_gene":"Last Exon: 47 or 48",
        "normal":"4\u201318",
        "normal_min":4.0,
        "normal_max":18.0,
        "intermediate":"19",
        "intermediate_min":19.0,
        "intermediate_max":19.0,
        "pathogenic":"20\u201333",
        "pathogenic_min":20.0,
        "pathogenic_max":33.0,
        "ref_copies":13.3,
        "repeatunitlen":3,
        "age_onset":"Typical: 43-52 (GeneReview); Range: 16 (PMID: 23331413) - 73 (NBK1140)",
        "age_onset_min":16,
        "age_onset_max":73,
        "typ_age_onset_min":43.0,
        "typ_age_onset_max":52.0,
        "novel":"ref",
        "Mechanism":"Polyglutamine ",
        "Mechanism_detail":"Polyglutamine ",
        "Mechanism_source":"(doi.org\/10.1038\/nrg.2017.115) (doi.org\/10.1007\/s11604-022-01343-5)",
        "source":"Hannan 2018, Mirkin 2007, GeneReviews NBK535148, s40478-021-01201-x",
        "notes":null,
        "details":null,
        "width":39.0,
        "OMIM":"183086",
        "Prevalence":"2.65\/100000",
        "Prevalence_details":"13-15% of global SCA prevalence, estimated to be 0.02-31\/100,000 (GeneReview); Tang et al., 2017: 0.3-5\/100,000",
        "STRipy_gene":"CACNA1A",
        "gnomAD_gene":"CACNA1A",
        "GeneReviews":"NBK1140",
        "Year":1997.0
    },
    {
        "chrom":"chr11",
        "start_hg38":119206289,
        "stop_hg38":119206322,
        "start_hg19":119076999,
        "stop_hg19":119077032,
        "start_t2t":119226663,
        "stop_t2t":119226696,
        "notes_t2t":"(CGG)11.3",
        "id":"JBS_CBL",
        "disease_id":"JBS",
        "gene_strand":"+",
        "reference_motif_reference_orientation":"CGG",
        "pathogenic_motif_reference_orientation":"CGG",
        "pathogenic_motif_gene_orientation":"CGG",
        "benign_motif_reference_orientation":null,
        "benign_motif_gene_orientation":"",
        "unknown_motif_reference_orientation":null,
        "unknown_motif_gene_orientation":"",
        "disease":"Jacobsen syndrome (FRAX11B fragile site)",
        "gene":"CBL",
        "flank_motif":null,
        "locus_structure":"(CGG)*",
        "Inheritance":"AD",
        "type":"5' UTR",
        "location_in_gene":null,
        "normal":"<79",
        "normal_min":11.0,
        "normal_max":79.0,
        "intermediate":null,
        "intermediate_min":null,
        "intermediate_max":null,
        "pathogenic":">100",
        "pathogenic_min":100.0,
        "pathogenic_max":100.0,
        "ref_copies":11.3,
        "repeatunitlen":3,
        "age_onset":"Condition at birth.",
        "age_onset_min":0,
        "age_onset_max":0,
        "typ_age_onset_min":null,
        "typ_age_onset_max":null,
        "novel":"ref",
        "Mechanism":"DNA hypermethylation and 11q deletion",
        "Mechanism_detail":"DNA hypermethylation/11q deletion in sporadic cases",
        "Mechanism_source":"PMID: 38467784",
        "source":"https:\/\/doi.org\/10.1038\/s41580-021-00382-6, 7603564 (PubMed)",
        "notes":null,
        "details":null,
        "width":33.0,
        "OMIM":"147791",
        "Prevalence":null,
        "Prevalence_details":"1\/100,000 births; female\/male ratio 2:1 (PMID: 19267933); expansion can lead to deletion (shown in 2 cases) but total causality is unclear",
        "STRipy_gene":"CBL",
        "gnomAD_gene":null,
        "GeneReviews":null,
        "Year":null
    },
    {
        "chrom":"chr3",
        "start_hg38":129172577,
        "stop_hg38":129172659,
        "start_hg19":128891420,
        "stop_hg19":128891502,
        "start_t2t":131917483,
        "stop_t2t":131917557,
        "notes_t2t":"(CAGG)18.8",
        "id":"DM2_CNBP",
        "disease_id":"DM2",
        "gene_strand":"-",
        "reference_motif_reference_orientation":"CAGG",
        "pathogenic_motif_reference_orientation":"CAGG",
        "pathogenic_motif_gene_orientation":"CCTG",
        "benign_motif_reference_orientation":null,
        "benign_motif_gene_orientation":"",
        "unknown_motif_reference_orientation":null,
        "unknown_motif_gene_orientation":"",
        "disease":"Myotonic Dystrophy Type 2",
        "gene":"CNBP",
        "flank_motif":"(CAGG)n(CAGA)10(CA)19",
        "locus_structure":"(CAGG)*(CAGA)*(CA)*",
        "Inheritance":"AD",
        "type":"Intronic",
        "location_in_gene":null,
        "normal":"11\u201326",
        "normal_min":11.0,
        "normal_max":26.0,
        "intermediate":"27-74",
        "intermediate_min":27.0,
        "intermediate_max":74.0,
        "pathogenic":"75-11,000",
        "pathogenic_min":75.0,
        "pathogenic_max":11000.0,
        "ref_copies":20.8,
        "repeatunitlen":4,
        "age_onset":"Typical: 28-56 (PMID: 29086017); Range: 0-73 (PMID: 31159885)",
        "age_onset_min":0,
        "age_onset_max":73,
        "typ_age_onset_min":28.0,
        "typ_age_onset_max":56.0,
        "novel":"ref",
        "Mechanism":"Aberrant splicing",
        "Mechanism_detail":"Aberrant splicing",
        "Mechanism_source":"(doi.org\/10.1093\/hmg\/ddr568)",
        "source":"Hannan 2018, Mirkin 2007, GeneReviews NBK1466, https:\/\/doi.org\/10.1038\/s41580-021-00382-6",
        "notes":"(TG)n(TCTG)n(CCTG)n. CCTG expansion causes DM2 but the other repeat units are also variable. Interruptions include GCTG/TCTG/GGCT (PMID: 35245110)",
        "details":"Penetrance is age-dependent and approaches 100%",
        "width":82.0,
        "OMIM":"602668",
        "Prevalence":"2.29\/100000",
        "Prevalence_details":"2.29\/100,000 (PMID: 35483324); population specific prevalence (GeneReview)",
        "STRipy_gene":"CNBP",
        "gnomAD_gene":"CNBP",
        "GeneReviews":"NBK1466",
        "Year":2001.0
    },
    {
        "chrom":"chr19",
        "start_hg38":18786034,
        "stop_hg38":18786049,
        "start_hg19":18896844,
        "stop_hg19":18896859,
        "start_t2t":18921630,
        "stop_t2t":18921645,
        "notes_t2t":null,
        "id":"EDM1-PSACH_COMP",
        "disease_id":"EDM1, PSACH",
        "gene_strand":"-",
        "reference_motif_reference_orientation":"GTC",
        "pathogenic_motif_reference_orientation":"GTC",
        "pathogenic_motif_gene_orientation":"ACG",
        "benign_motif_reference_orientation":null,
        "benign_motif_gene_orientation":"",
        "unknown_motif_reference_orientation":null,
        "unknown_motif_gene_orientation":"",
        "disease":"Multiple epiphyseal dysplasia, Pseudoachondroplasia",
        "gene":"COMP",
        "flank_motif":null,
        "locus_structure":"(GTC)*",
        "Inheritance":"AD",
        "type":"Coding",
        "location_in_gene":null,
        "normal":"5",
        "normal_min":5.0,
        "normal_max":5.0,
        "intermediate":null,
        "intermediate_min":null,
        "intermediate_max":null,
        "pathogenic":"4 or 6-7",
        "pathogenic_min":6.0,
        "pathogenic_max":7.0,
        "ref_copies":5.0,
        "repeatunitlen":3,
        "age_onset":"Typical: 0-2 (COMP-PSACH)\/ 1-12 (EDM1); Range: 0 (PSACH) - 13 (EDM1); 3-13 specific to trinucleotide expansions (duplications), several contractions but unknown exact AoO",
        "age_onset_min":3,
        "age_onset_max":13,
        "typ_age_onset_min":null,
        "typ_age_onset_max":null,
        "novel":"ref",
        "Mechanism":"Protein LOF",
        "Mechanism_detail":"LOF, domain dependent",
        "Mechanism_source":"(https:\/\/pubmed.ncbi.nlm.nih.gov\/29530484\/)",
        "source":"Pathogenic Short Tandem Repeats Gnomad v3.1.2",
        "notes":"Two diseases, same locus. Both expansions and contractions associated with disease",
        "details":null,
        "width":15.0,
        "OMIM":"132400; 177170",
        "Prevalence":null,
        "Prevalence_details":"Specific contribution of COMP repeats to EDM1 is unknown (~300 COMP mutation variants for both phenotypes); likely 1:90,000 prevalence for COMP-PSACH that is repeat-specific.",
        "STRipy_gene":"COMP",
        "gnomAD_gene":"COMP",
        "GeneReviews":"NBK1123; NBK1487",
        "Year":null
    },
    {
        "chrom":"chr21",
        "start_hg38":43776443,
        "stop_hg38":43776479,
        "start_hg19":45196324,
        "stop_hg19":45196360,
        "start_t2t":42132055,
        "stop_t2t":42132091,
        "notes_t2t":null,
        "id":"EPM1_CSTB",
        "disease_id":"EPM1",
        "gene_strand":"-",
        "reference_motif_reference_orientation":"CGCGGGGCGGGG",
        "pathogenic_motif_reference_orientation":"CGCGGGGCGGGG",
        "pathogenic_motif_gene_orientation":"CCCCGCCCCGCG",
        "benign_motif_reference_orientation":null,
        "benign_motif_gene_orientation":"",
        "unknown_motif_reference_orientation":null,
        "unknown_motif_gene_orientation":"",
        "disease":"Progressive Myoclonic Epilepsy Type 1 (EPM1) Unverricht-Lundborg Disease (ULD)",
        "gene":"CSTB",
        "flank_motif":null,
        "locus_structure":"(CGCGGGGCGGGG)*",
        "Inheritance":"AR",
        "type":"Promoter",
        "location_in_gene":null,
        "normal":"2-3",
        "normal_min":2.0,
        "normal_max":3.0,
        "intermediate":"12-17",
        "intermediate_min":12.0,
        "intermediate_max":17.0,
        "pathogenic":">=30",
        "pathogenic_min":30.0,
        "pathogenic_max":81.0,
        "ref_copies":null,
        "repeatunitlen":12,
        "age_onset":"Typical: 6-15  (GeneReview); Range: 6-16 (PMID: 9012407)",
        "age_onset_min":6,
        "age_onset_max":16,
        "typ_age_onset_min":6.0,
        "typ_age_onset_max":15.0,
        "novel":null,
        "Mechanism":"LOF",
        "Mechanism_detail":"LoF",
        "Mechanism_source":"PMID: 38467784",
        "source":"OMIM, https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK1142\/, PMID: 9126745",
        "notes":null,
        "details":null,
        "width":null,
        "OMIM":"254800",
        "Prevalence":null,
        "Prevalence_details":"Worldwide prevalence unknown; Finland prevalence 2-4\/100,000",
        "STRipy_gene":null,
        "gnomAD_gene":"CSTB",
        "GeneReviews":"NBK1142",
        "Year":1997.0
    },
    {
        "chrom":"chr1",
        "start_hg38":57367044,
        "stop_hg38":57367125,
        "start_hg19":57832716,
        "stop_hg19":57832797,
        "start_t2t":57245936,
        "stop_t2t":57245977,
        "notes_t2t":"(AAAAT)8.6",
        "id":"SCA37_DAB1",
        "disease_id":"SCA37",
        "gene_strand":"-",
        "reference_motif_reference_orientation":"AAAAT",
        "pathogenic_motif_reference_orientation":"GAAAT",
        "pathogenic_motif_gene_orientation":"ATTTC",
        "benign_motif_reference_orientation":null,
        "benign_motif_gene_orientation":"",
        "unknown_motif_reference_orientation":"AAAAA",
        "unknown_motif_gene_orientation":"TTTTT",
        "disease":"Spinocerebellar Ataxia Type 37",
        "gene":"DAB1",
        "flank_motif":null,
        "locus_structure":"(AAAAT)*(GAAAT)*(AAAAT)*",
        "Inheritance":"AD",
        "type":"Intronic",
        "location_in_gene":"Intron 1 (most isoforms)",
        "normal":"0-16",
        "normal_min":0.0,
        "normal_max":16.0,
        "intermediate":null,
        "intermediate_min":null,
        "intermediate_max":null,
        "pathogenic":"31-75",
        "pathogenic_min":31.0,
        "pathogenic_max":75.0,
        "ref_copies":16.6,
        "repeatunitlen":5,
        "age_onset":"Typical: 33-53; Range: 18-64 (GeneReview)",
        "age_onset_min":18,
        "age_onset_max":64,
        "typ_age_onset_min":33.0,
        "typ_age_onset_max":53.0,
        "novel":"novel",
        "Mechanism":"Protein toxic GOF",
        "Mechanism_detail":"toxic gain-of-function mechanism",
        "Mechanism_source":"(OMIM)",
        "source":"Seixas et al 2017 AJHG, NBK541729, s40478-021-01201-x",
        "notes":"Novel. Normal: [(ATTTT)7\u2013400] Pathogenic: [(ATTTT)60\u201379(ATTTC)31\u201375(ATTTT)58\u201390], ATTTC within (ATTTT)7\u2013400 repeat region",
        "details":null,
        "width":81.0,
        "OMIM":"615945",
        "Prevalence":null,
        "Prevalence_details":"0.20\/100,000 specific to Portugal; not yet found in other geographic regions",
        "STRipy_gene":"DAB1",
        "gnomAD_gene":"DAB1",
        "GeneReviews":"NBK541729",
        "Year":2017.0
    },
    {
        "chrom":"chr12",
        "start_hg38":50505002,
        "stop_hg38":50505022,
        "start_hg19":50898785,
        "stop_hg19":50898805,
        "start_t2t":50468096,
        "stop_t2t":50468116,
        "notes_t2t":null,
        "id":"FRA12A_DIP2B",
        "disease_id":"FRA12A",
        "gene_strand":"+",
        "reference_motif_reference_orientation":"GGC",
        "pathogenic_motif_reference_orientation":"GGC",
        "pathogenic_motif_gene_orientation":"CGG",
        "benign_motif_reference_orientation":null,
        "benign_motif_gene_orientation":"",
        "unknown_motif_reference_orientation":null,
        "unknown_motif_gene_orientation":"",
        "disease":"Intellectual developmental disorder, FRA12A type",
        "gene":"DIP2B",
        "flank_motif":null,
        "locus_structure":"(GGC)*",
        "Inheritance":"AD",
        "type":"5' UTR",
        "location_in_gene":null,
        "normal":"6-23",
        "normal_min":6.0,
        "normal_max":23.0,
        "intermediate":"~139-206",
        "intermediate_min":139.0,
        "intermediate_max":206.0,
        "pathogenic":"~273-306",
        "pathogenic_min":273.0,
        "pathogenic_max":306.0,
        "ref_copies":7.0,
        "repeatunitlen":3,
        "age_onset":"Typical: 0-1 (PMID: 3742859) (small sample size); Range: 0-3 (PMID: 4042396)",
        "age_onset_min":0,
        "age_onset_max":3,
        "typ_age_onset_min":null,
        "typ_age_onset_max":null,
        "novel":"ref",
        "Mechanism":"Increased gene expression, methylation",
        "Mechanism_detail":"Increased gene expression, methylation",
        "Mechanism_source":"(OMIM, https:\/\/www.medrxiv.org\/content\/10.1101\/2022.09.12.22279739v3.full-text)",
        "source":"OMIM, NBK535148, https:\/\/www.medrxiv.org\/content\/10.1101\/2022.09.12.22279739v3.full-text",
        "notes":null,
        "details":null,
        "width":20.0,
        "OMIM":"136630",
        "Prevalence":null,
        "Prevalence_details":null,
        "STRipy_gene":"DIP2B",
        "gnomAD_gene":"DIP2B",
        "GeneReviews":"NBK535148",
        "Year":null
    },
    {
        "chrom":"chrX",
        "start_hg38":31284557,
        "stop_hg38":31284605,
        "start_hg19":31302674,
        "stop_hg19":31302722,
        "start_t2t":30882695,
        "stop_t2t":30882743,
        "notes_t2t":"(TTC)22.7",
        "id":"DMD_DMD",
        "disease_id":"DMD",
        "gene_strand":"-",
        "reference_motif_reference_orientation":"TTC",
        "pathogenic_motif_reference_orientation":"TTC",
        "pathogenic_motif_gene_orientation":"AAG",
        "benign_motif_reference_orientation":null,
        "benign_motif_gene_orientation":"",
        "unknown_motif_reference_orientation":null,
        "unknown_motif_gene_orientation":"",
        "disease":"Duchenne muscular dystrophy",
        "gene":"DMD",
        "flank_motif":null,
        "locus_structure":"(TTC)*",
        "Inheritance":"XR",
        "type":"Intronic",
        "location_in_gene":null,
        "normal":"<33",
        "normal_min":16.0,
        "normal_max":33.0,
        "intermediate":null,
        "intermediate_min":null,
        "intermediate_max":null,
        "pathogenic":">59",
        "pathogenic_min":59.0,
        "pathogenic_max":82.0,
        "ref_copies":16.7,
        "repeatunitlen":3,
        "age_onset":"Typical: 6-7 (usual disease is 0-3)",
        "age_onset_min":6,
        "age_onset_max":7,
        "typ_age_onset_min":null,
        "typ_age_onset_max":null,
        "novel":"ref",
        "Mechanism":"Protein LOF",
        "Mechanism_detail":"Functional defect in dystrophin\/dystroglycan",
        "Mechanism_source":"(https:\/\/doi.org\/10.1007\/s10038-006-0056-7)",
        "source":"PMID: 27417533",
        "notes":null,
        "details":"There is conflicting evidence for the association between this repeat expansion and Duchenne muscular dystrophy. The association was reported in a single family (PMID: 27417533). The population frequency of the proposed pathogenic allele is much higher than expected for a highly penetrant early-onset condition.",
        "width":48.0,
        "OMIM":"310200",
        "Prevalence":"4.8\/100000",
        "Prevalence_details":"Believed to be 0 for disease specific to STR expansion. 1\/3500-4700 male births (incidence) for overall DMD (one of the most common and severe congenital myopathies). 4.8\/100,000 prevalence PMID: 35168641",
        "STRipy_gene":"DMD",
        "gnomAD_gene":"DMD",
        "GeneReviews":"NBK535148",
        "Year":null
    },
    {
        "chrom":"chr19",
        "start_hg38":45770204,
        "stop_hg38":45770266,
        "start_hg19":46273462,
        "stop_hg19":46273524,
        "start_t2t":48597739,
        "stop_t2t":48597756,
        "notes_t2t":null,
        "id":"DM1_DMPK",
        "disease_id":"DM1",
        "gene_strand":"-",
        "reference_motif_reference_orientation":"CAG",
        "pathogenic_motif_reference_orientation":"CAG",
        "pathogenic_motif_gene_orientation":"CTG",
        "benign_motif_reference_orientation":null,
        "benign_motif_gene_orientation":"",
        "unknown_motif_reference_orientation":null,
        "unknown_motif_gene_orientation":"",
        "disease":"Myotonic Dystrophy Type 1",
        "gene":"DMPK",
        "flank_motif":null,
        "locus_structure":"(CAG)*",
        "Inheritance":"AD",
        "type":"3' UTR",
        "location_in_gene":"Last exon",
        "normal":"5\u201334",
        "normal_min":5.0,
        "normal_max":34.0,
        "intermediate":"35-49",
        "intermediate_min":35.0,
        "intermediate_max":49.0,
        "pathogenic":"50-1000",
        "pathogenic_min":50.0,
        "pathogenic_max":1000.0,
        "ref_copies":20.7,
        "repeatunitlen":3,
        "age_onset":"Typical: 10-30 (\"classic\", GeneReview); Range: 0-74 (PMID: 38454488)",
        "age_onset_min":0,
        "age_onset_max":74,
        "typ_age_onset_min":10.0,
        "typ_age_onset_max":30.0,
        "novel":"ref",
        "Mechanism":"RNA GOF",
        "Mechanism_detail":"RNA gain-of-function - RNA gelation leading to misregulation of alternative splicing",
        "Mechanism_source":"(doi.org\/10.1007\/s11604-022-01343-5)",
        "source":"Hannan 2018, Mirkin 2007, GeneReviews NBK1165, s40478-021-01201-x",
        "notes":"'3%-8% of DM1 expansions contain variant repeats such as CCG and CGG. These are referred to as variant repeat interruptions and may be associated with later onset and milder phenotype [Miller et al 2020].'(GeneReviews) 'Interruptions of the CTG repeat with CCG, GGC, CTC or CAG motifs are estimated to occur in 3–11% of DM1 patients' (PMID: 35741732)",
        "details":null,
        "width":62.0,
        "OMIM":"160900",
        "Prevalence":"9.27\/100000",
        "Prevalence_details":"5-20\/100,000 (GeneReview); Tang et al., 2017: 0.5-18.1\/100,000; 6.5\/100,000 (PMID: 31159885) ; 9.27 cases (95% CI: 4.73-15.21) per 100,000, ranging from 0.37 to 36.29 cases per 100,000 (PMID: 35483324)",
        "STRipy_gene":"DMPK",
        "gnomAD_gene":"DMPK",
        "GeneReviews":"NBK1165",
        "Year":1992.0
    },
    {
        "chrom":"chr17",
        "start_hg38":80147059,
        "stop_hg38":80147139,
        "start_hg19":78120858,
        "stop_hg19":78120938,
        "start_t2t":81047454,
        "stop_t2t":81047534,
        "notes_t2t":null,
        "id":"RCPS_EIF4A3",
        "disease_id":"RCPS",
        "gene_strand":"-",
        "reference_motif_reference_orientation":"CCTCGCTGTGCCGCTGCCGA",
        "pathogenic_motif_reference_orientation":"CCTCGCTGTGCCGCTGCCGA",
        "pathogenic_motif_gene_orientation":"ACAGCGAGGTCGGCAGCGGC",
        "benign_motif_reference_orientation":null,
        "benign_motif_gene_orientation":"",
        "unknown_motif_reference_orientation":null,
        "unknown_motif_gene_orientation":"",
        "disease":"Richieri-Costa-Pereira syndrome",
        "gene":"EIF4A3",
        "flank_motif":null,
        "locus_structure":"(CCTCGCTGCGCCGCTGCCGA)*(CCTCGCTGTGCCGCTGCCGA)*",
        "Inheritance":"AR",
        "type":"5' UTR",
        "location_in_gene":null,
        "normal":"1-9",
        "normal_min":1.0,
        "normal_max":9.0,
        "intermediate":"10-13",
        "intermediate_min":10.0,
        "intermediate_max":13.0,
        "pathogenic":">14",
        "pathogenic_min":14.0,
        "pathogenic_max":16.0,
        "ref_copies":null,
        "repeatunitlen":20,
        "age_onset":"0 (birth)",
        "age_onset_min":0,
        "age_onset_max":0,
        "typ_age_onset_min":0.0,
        "typ_age_onset_max":0.0,
        "novel":null,
        "Mechanism":"LoF",
        "Mechanism_detail":"LoF",
        "Mechanism_source":"PMID: 38467784",
        "source":"https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK535148\/",
        "notes":null,
        "details":"Complex repeat (GeneReview).",
        "width":null,
        "OMIM":"268305",
        "Prevalence":null,
        "Prevalence_details":"49 cases as of Nov 2023 (doi.org\/10.1016\/j.omsc.2023.100340)",
        "STRipy_gene":null,
        "gnomAD_gene":"EIF4A3",
        "GeneReviews":"NBK535148",
        "Year":null
    },
    {
        "chrom":"chr13",
        "start_hg38":102161577,
        "stop_hg38":102161726,
        "start_hg19":102813927,
        "stop_hg19":102814076,
        "start_t2t":101377640,
        "stop_t2t":101377789,
        "notes_t2t":null,
        "id":"SCA27B_FGF14",
        "disease_id":"SCA27B",
        "gene_strand":"-",
        "reference_motif_reference_orientation":"GAA",
        "pathogenic_motif_reference_orientation":"GAA",
        "pathogenic_motif_gene_orientation":"CTT",
        "benign_motif_reference_orientation":"GAAGGA, GAAGAAGAAGAAGCA",
        "benign_motif_gene_orientation":"",
        "unknown_motif_reference_orientation":null,
        "unknown_motif_gene_orientation":"",
        "disease":"Spinocerebellar ataxia 27B",
        "gene":"FGF14",
        "flank_motif":null,
        "locus_structure":"(GAA)*",
        "Inheritance":"AD",
        "type":"Intronic",
        "location_in_gene":"Intron 1",
        "normal":"8-249",
        "normal_min":8.0,
        "normal_max":249.0,
        "intermediate":"250-299",
        "intermediate_min":250.0,
        "intermediate_max":299.0,
        "pathogenic":">300",
        "pathogenic_min":300.0,
        "pathogenic_max":637.0,
        "ref_copies":50.3,
        "repeatunitlen":3,
        "age_onset":"Typical: 42-70; Range: 21-87 (NBK599589)",
        "age_onset_min":21,
        "age_onset_max":87,
        "typ_age_onset_min":42.0,
        "typ_age_onset_max":70.0,
        "novel":"ref",
        "Mechanism":"Haploinsufficiency",
        "Mechanism_detail":"Reduced transcript 2",
        "Mechanism_source":"PMCID: PMC10042577",
        "source":"https:\/\/www.omim.org\/entry\/620174, https:\/\/www.cell.com\/ajhg\/fulltext\/S0002-9297(22)00506-7, PMCID: PMC10042577, PMID: 37399286",
        "notes":"250-300 pathogenic with incomplete penetrance, >300 complete penetrance",
        "details":"Incomplete penetrance.",
        "width":null,
        "OMIM":"620174",
        "Prevalence":null,
        "Prevalence_details":"Intermediate expansions 1-2% of population, but non-GAA-pure without relation to ataxia. (GeneReview)",
        "STRipy_gene":"FGF14",
        "gnomAD_gene":null,
        "GeneReviews":"NBK599589",
        "Year":2023.0
    },
    {
        "chrom":"chrX",
        "start_hg38":147912037,
        "stop_hg38":147912111,
        "start_hg19":146993555,
        "stop_hg19":146993629,
        "start_t2t":146176665,
        "stop_t2t":146176769,
        "notes_t2t":"(GGC)35.0",
        "id":"FXS_FMR1",
        "disease_id":"FXS, FXTAS, POF1",
        "gene_strand":"+",
        "reference_motif_reference_orientation":"CGG",
        "pathogenic_motif_reference_orientation":"CGG",
        "pathogenic_motif_gene_orientation":"CGG",
        "benign_motif_reference_orientation":null,
        "benign_motif_gene_orientation":"",
        "unknown_motif_reference_orientation":null,
        "unknown_motif_gene_orientation":"",
        "disease":"Fragile X syndrome (FXS), fragile X-associated tremor\/ataxia syndrome (FXTAS), and fragile X-associated primary ovarian insufficiency FXPOI\/POF1",
        "gene":"FMR1",
        "flank_motif":null,
        "locus_structure":"(CGG)*",
        "Inheritance":"XD",
        "type":"5' UTR",
        "location_in_gene":"Exon 2",
        "normal":"5\u201344",
        "normal_min":5.0,
        "normal_max":44.0,
        "intermediate":"45-200",
        "intermediate_min":45.0,
        "intermediate_max":200.0,
        "pathogenic":"200-2000",
        "pathogenic_min":200.0,
        "pathogenic_max":2000.0,
        "ref_copies":20.6667,
        "repeatunitlen":3,
        "age_onset":"Typical: FXS 1 to \"first several yeares of life\", FXTAS 60-65 (GeneReview); Range: 0 (FXS, UptoDate) - 78 (PMID: 17427188)",
        "age_onset_min":0,
        "age_onset_max":78,
        "typ_age_onset_min":1.0,
        "typ_age_onset_max":65.0,
        "novel":"ref",
        "Mechanism":"LOF via decreased gene expression in FXS, GOF in FXTAS",
        "Mechanism_detail":"Loss of function via transcriptional silencing in FXSRNA GOF in FXTAS",
        "Mechanism_source":"(doi.org\/10.1038\/nrg1691) (doi.org\/10.1007\/s11604-022-01343-5)",
        "source":"Hannan 2018, Mirkin 2007, NBK1384",
        "notes":"FXTAS\/POI 55\u2013200, FXS >200, late onset; AGG and CTG interruptions (GeneReviews & PMID: 29868108)",
        "details":null,
        "width":74.0,
        "OMIM":"300624; 300623",
        "Prevalence":"14\/100000",
        "Prevalence_details":"Incidence of full mutation in males 19\/100,000; prevalence 14\/100,000 (GeneReviews). Female prevalence 9\/100,000 (PMID: 24700618). Tang et al., 2017: known carrier frequency 300-500\/100,000 but detected was 11\/100,000",
        "STRipy_gene":"FMR1",
        "gnomAD_gene":"FMR1",
        "GeneReviews":"NBK1384",
        "Year":1991.0
    },
    {
        "chrom":"chr3",
        "start_hg38":138946020,
        "stop_hg38":138946062,
        "start_hg19":138664862,
        "stop_hg19":138664904,
        "start_t2t":141687014,
        "stop_t2t":141687051,
        "notes_t2t":"(GCGGCTGCAGCCGCA)2.5",
        "id":"BPES_FOXL2",
        "disease_id":"BPES",
        "gene_strand":"-",
        "reference_motif_reference_orientation":"NGC",
        "pathogenic_motif_reference_orientation":"NGC",
        "pathogenic_motif_gene_orientation":"CNG",
        "benign_motif_reference_orientation":null,
        "benign_motif_gene_orientation":"",
        "unknown_motif_reference_orientation":null,
        "unknown_motif_gene_orientation":"",
        "disease":"Blepharophimosis, epicanthus inversus, and ptosis",
        "gene":"FOXL2",
        "flank_motif":null,
        "locus_structure":"(NGC)*",
        "Inheritance":"AD",
        "type":"Coding",
        "location_in_gene":"Exon 1",
        "normal":"<14",
        "normal_min":14.0,
        "normal_max":14.0,
        "intermediate":null,
        "intermediate_min":null,
        "intermediate_max":null,
        "pathogenic":">15",
        "pathogenic_min":15.0,
        "pathogenic_max":15.0,
        "ref_copies":14.0,
        "repeatunitlen":3,
        "age_onset":"0 (birth)",
        "age_onset_min":0,
        "age_onset_max":0,
        "typ_age_onset_min":0.0,
        "typ_age_onset_max":0.0,
        "novel":"ref",
        "Mechanism":"Polyalanine",
        "Mechanism_detail":"Polyalanine",
        "Mechanism_source":"(doi.org\/10.1038\/nature05977) (doi.org\/10.1007\/s11604-022-01343-5)",
        "source":"NBK535148",
        "notes":null,
        "details":null,
        "width":42.0,
        "OMIM":"110100",
        "Prevalence":"0.3\/50000",
        "Prevalence_details":"1 in 50,000 births globally for all BPES, with FOXL2 expansions 30% of pathogenic variants (NBK1441; NBK535148 (PMID: 12529855))",
        "STRipy_gene":"FOXL2",
        "gnomAD_gene":"FOXL2",
        "GeneReviews":"NBK535148",
        "Year":2001.0
    },
    {
        "chrom":"chr9",
        "start_hg38":69037286,
        "stop_hg38":69037304,
        "start_hg19":71652202,
        "stop_hg19":71652220,
        "start_t2t":81210843,
        "stop_t2t":81210861,
        "notes_t2t":"(AAG)9.7",
        "id":"FRDA_FXN",
        "disease_id":"FRDA",
        "gene_strand":"+",
        "reference_motif_reference_orientation":"GAA",
        "pathogenic_motif_reference_orientation":"GAA",
        "pathogenic_motif_gene_orientation":"AAG",
        "benign_motif_reference_orientation":null,
        "benign_motif_gene_orientation":"",
        "unknown_motif_reference_orientation":null,
        "unknown_motif_gene_orientation":"",
        "disease":"Friedreich ataxia",
        "gene":"FXN",
        "flank_motif":"(A)16(GAA)n",
        "locus_structure":"(A)*(GAA)*",
        "Inheritance":"AR",
        "type":"Intronic",
        "location_in_gene":"Intron 1",
        "normal":"5\u201333",
        "normal_min":5.0,
        "normal_max":33.0,
        "intermediate":"34-65",
        "intermediate_min":34.0,
        "intermediate_max":65.0,
        "pathogenic":"66 to 1700",
        "pathogenic_min":66.0,
        "pathogenic_max":1700.0,
        "ref_copies":6.0,
        "repeatunitlen":3,
        "age_onset":"Typical: 10-15; Range: 2-80 (GeneReview)",
        "age_onset_min":2,
        "age_onset_max":80,
        "typ_age_onset_min":10.0,
        "typ_age_onset_max":15.0,
        "novel":"ref",
        "Mechanism":"LOF, reduced gene expression",
        "Mechanism_detail":"Loss of function via transcriptional silencing",
        "Mechanism_source":"(doi.org\/10.1038\/nrg1691) (doi.org\/10.1007\/s11604-022-01343-5)",
        "source":"Hannan 2018, Mirkin 2007, GeneReviews NBK535148",
        "notes":"Not annotated by TRF? 'The expanded repeats were interrupted either with GAAGAG, GAAGGA, or GAAGAAAA sequences.' (PMID: 11748752)",
        "details":null,
        "width":2.0,
        "OMIM":"229300",
        "Prevalence":"1\/50000",
        "Prevalence_details":"1\/50,000 (OMIM); Tang et al., 2017: Known carrier frequency 1000\/100,000; observed 421\/100,000",
        "STRipy_gene":"FXN",
        "gnomAD_gene":"FXN",
        "GeneReviews":"NBK1281",
        "Year":1996.0
    },
    {
        "chrom":"chr19",
        "start_hg38":14496041,
        "stop_hg38":14496074,
        "start_hg19":14606853,
        "stop_hg19":14606886,
        "start_t2t":14622656,
        "stop_t2t":14622702,
        "notes_t2t":"(CCG)15.7",
        "id":"OPDM2_GIPC1",
        "disease_id":"OPDM2",
        "gene_strand":"-",
        "reference_motif_reference_orientation":"CCG",
        "pathogenic_motif_reference_orientation":"CCG",
        "pathogenic_motif_gene_orientation":"CGG",
        "benign_motif_reference_orientation":null,
        "benign_motif_gene_orientation":"",
        "unknown_motif_reference_orientation":null,
        "unknown_motif_gene_orientation":"",
        "disease":"Oculopharyngodistal myopathy",
        "gene":"GIPC1",
        "flank_motif":null,
        "locus_structure":"(CCG)*",
        "Inheritance":"AD",
        "type":"5' UTR",
        "location_in_gene":"Exon 1",
        "normal":"6-29",
        "normal_min":6.0,
        "normal_max":29.0,
        "intermediate":null,
        "intermediate_min":null,
        "intermediate_max":null,
        "pathogenic":"70-138",
        "pathogenic_min":70.0,
        "pathogenic_max":138.0,
        "ref_copies":14.7,
        "repeatunitlen":3,
        "age_onset":"Typical: 20-34 (PMID: 32413282); Range: 14 (PMID: ...282) - 70 (PMID: 33374016)",
        "age_onset_min":14,
        "age_onset_max":70,
        "typ_age_onset_min":20.0,
        "typ_age_onset_max":34.0,
        "novel":"ref",
        "Mechanism":"RNA toxicity",
        "Mechanism_detail":"RNA mediated toxicity hypothesized; unknown",
        "Mechanism_source":"(OMIM), (doi.org\/10.1007\/s11604-022-01343-5)",
        "source":"Pathogenic Short Tandem Repeats Gnomad v3.1.2, 32413282 (Pubmed)",
        "notes":"Interruptions Seen: CGA (PMID: 35245110); Interruptions mentioned but not confirmed in primary literature: TCG/CCT/TTG (PMID: 38467784)",
        "details":null,
        "width":33.0,
        "OMIM":"618940",
        "Prevalence":null,
        "Prevalence_details":"Population dependent; presumed rare.",
        "STRipy_gene":"GIPC1",
        "gnomAD_gene":"GIPC1",
        "GeneReviews":"NBK535148",
        "Year":2020.0
    },
    {
        "chrom":"chr2",
        "start_hg38":190880873,
        "stop_hg38":190880920,
        "start_hg19":191745599,
        "stop_hg19":191745646,
        "start_t2t":191369983,
        "stop_t2t":191370024,
        "notes_t2t":"(GCA)14.0",
        "id":"GDPAG_GLS",
        "disease_id":"GDPAG",
        "gene_strand":"+",
        "reference_motif_reference_orientation":"GCA",
        "pathogenic_motif_reference_orientation":"GCA",
        "pathogenic_motif_gene_orientation":"AGC",
        "benign_motif_reference_orientation":null,
        "benign_motif_gene_orientation":"",
        "unknown_motif_reference_orientation":null,
        "unknown_motif_gene_orientation":"",
        "disease":"Glutaminase deficiency",
        "gene":"GLS",
        "flank_motif":null,
        "locus_structure":"(GCA)*",
        "Inheritance":"AR",
        "type":"5' UTR",
        "location_in_gene":"Exon 1",
        "normal":"5-26",
        "normal_min":5.0,
        "normal_max":26.0,
        "intermediate":null,
        "intermediate_min":null,
        "intermediate_max":null,
        "pathogenic":"90 - 1500",
        "pathogenic_min":90.0,
        "pathogenic_max":1500.0,
        "ref_copies":16.0,
        "repeatunitlen":3,
        "age_onset":"Early childhood (2-4; PMID: 30970188, 35913761)",
        "age_onset_min":2,
        "age_onset_max":4,
        "typ_age_onset_min":null,
        "typ_age_onset_max":null,
        "novel":"ref",
        "Mechanism":"Decreased gene expression, methylation",
        "Mechanism_detail":"Change in histone modification decreases transcription",
        "Mechanism_source":"(OMIM)",
        "source":"van Kuilenburg 2019 NEJM, 30970188 (Pubmed)",
        "notes":"Several compound het cases reported",
        "details":null,
        "width":47.0,
        "OMIM":"618412",
        "Prevalence":null,
        "Prevalence_details":"As of 2019, only 7 cases total of GLS deficiency, including non-repeat",
        "STRipy_gene":"GLS",
        "gnomAD_gene":"GLS",
        "GeneReviews":"NBK535148",
        "Year":2019.0
    },
    {
        "chrom":"chr7",
        "start_hg38":27199924,
        "stop_hg38":27199966,
        "start_hg19":27239543,
        "stop_hg19":27239585,
        "start_t2t":27335920,
        "stop_t2t":27335951,
        "notes_t2t":"(GCAGCCGCCGCCGCT)2.7",
        "id":"HFG_HOXA13-I",
        "disease_id":"HFG-I",
        "gene_strand":"-",
        "reference_motif_reference_orientation":"NGC",
        "pathogenic_motif_reference_orientation":"NGC",
        "pathogenic_motif_gene_orientation":"CNG",
        "benign_motif_reference_orientation":null,
        "benign_motif_gene_orientation":"",
        "unknown_motif_reference_orientation":null,
        "unknown_motif_gene_orientation":"",
        "disease":"Hand-foot-genital syndrome 1",
        "gene":"HOXA13",
        "flank_motif":null,
        "locus_structure":"(NGC)*",
        "Inheritance":"AD",
        "type":"Coding",
        "location_in_gene":"Exon 1",
        "normal":"14",
        "normal_min":14.0,
        "normal_max":14.0,
        "intermediate":null,
        "intermediate_min":null,
        "intermediate_max":null,
        "pathogenic":"22",
        "pathogenic_min":22.0,
        "pathogenic_max":22.0,
        "ref_copies":14.0,
        "repeatunitlen":3,
        "age_onset":"0 (birth)",
        "age_onset_min":0,
        "age_onset_max":0,
        "typ_age_onset_min":null,
        "typ_age_onset_max":null,
        "novel":"ref",
        "Mechanism":"Polyalanine ",
        "Mechanism_detail":"Polyalanine ",
        "Mechanism_source":"(doi.org\/10.1038\/nature05977) (doi.org\/10.1007\/s11604-022-01343-5)",
        "source":"Pathogenic Short Tandem Repeats, Gnomad v3.1.2, NBK1423",
        "notes":"There are 3 pathogenic polyalanine tracts in this gene",
        "details":null,
        "width":42.0,
        "OMIM":"140000",
        "Prevalence":null,
        "Prevalence_details":"\"Extremely rare\" (GeneReview)",
        "STRipy_gene":"HOXA13_1",
        "gnomAD_gene":"HOXA13_1",
        "GeneReviews":"NBK1423",
        "Year":2000.0
    },
    {
        "chrom":"chr7",
        "start_hg38":27199825,
        "stop_hg38":27199861,
        "start_hg19":27239444,
        "stop_hg19":27239480,
        "start_t2t":27335914,
        "stop_t2t":27335954,
        "notes_t2t":"(GCAGCCGCCGCCGCT)2.9",
        "id":"HFG_HOXA13-II",
        "disease_id":"HFG-II",
        "gene_strand":"-",
        "reference_motif_reference_orientation":"NGC",
        "pathogenic_motif_reference_orientation":"NGC",
        "pathogenic_motif_gene_orientation":"CNG",
        "benign_motif_reference_orientation":null,
        "benign_motif_gene_orientation":"",
        "unknown_motif_reference_orientation":null,
        "unknown_motif_gene_orientation":"",
        "disease":"Hand-foot-genital syndrome 2",
        "gene":"HOXA13",
        "flank_motif":null,
        "locus_structure":"(NGC)*",
        "Inheritance":"AD",
        "type":"Coding",
        "location_in_gene":"Exon 1",
        "normal":"12",
        "normal_min":12.0,
        "normal_max":12.0,
        "intermediate":null,
        "intermediate_min":null,
        "intermediate_max":null,
        "pathogenic":"18",
        "pathogenic_min":18.0,
        "pathogenic_max":18.0,
        "ref_copies":12.0,
        "repeatunitlen":3,
        "age_onset":"0 (birth)",
        "age_onset_min":0,
        "age_onset_max":0,
        "typ_age_onset_min":null,
        "typ_age_onset_max":null,
        "novel":"ref",
        "Mechanism":"Polyalanine ",
        "Mechanism_detail":"Polyalanine ",
        "Mechanism_source":"(doi.org\/10.1038\/nature05977) (doi.org\/10.1007\/s11604-022-01343-5)",
        "source":"Pathogenic Short Tandem Repeats Gnomad v3.1.2,  NBK1423",
        "notes":"There are 3 pathogenic polyalanine tracts in this gene",
        "details":null,
        "width":36.0,
        "OMIM":"140000",
        "Prevalence":null,
        "Prevalence_details":"\"Extremely rare\" (GeneReview)",
        "STRipy_gene":"HOXA13_2",
        "gnomAD_gene":"HOXA13_2",
        "GeneReviews":"NBK1423",
        "Year":2000.0
    },
    {
        "chrom":"chr7",
        "start_hg38":27199678,
        "stop_hg38":27199732,
        "start_hg19":27239297,
        "stop_hg19":27239351,
        "start_t2t":27335815,
        "stop_t2t":27335849,
        "notes_t2t":"(GCCGCGGCCGCCGCCG)1.9",
        "id":"HFG_HOXA13-III",
        "disease_id":"HFG-III",
        "gene_strand":"-",
        "reference_motif_reference_orientation":"NGC",
        "pathogenic_motif_reference_orientation":"NGC",
        "pathogenic_motif_gene_orientation":"CNG",
        "benign_motif_reference_orientation":null,
        "benign_motif_gene_orientation":"",
        "unknown_motif_reference_orientation":null,
        "unknown_motif_gene_orientation":"",
        "disease":"Hand-foot-genital syndrome 3",
        "gene":"HOXA13",
        "flank_motif":null,
        "locus_structure":"(NGC)*",
        "Inheritance":"AD",
        "type":"Coding",
        "location_in_gene":"Exon 1",
        "normal":"8-18",
        "normal_min":8.0,
        "normal_max":18.0,
        "intermediate":null,
        "intermediate_min":null,
        "intermediate_max":null,
        "pathogenic":"24-32",
        "pathogenic_min":24.0,
        "pathogenic_max":32.0,
        "ref_copies":18.0,
        "repeatunitlen":3,
        "age_onset":"0 (birth)",
        "age_onset_min":0,
        "age_onset_max":0,
        "typ_age_onset_min":null,
        "typ_age_onset_max":null,
        "novel":"ref",
        "Mechanism":"Polyalanine ",
        "Mechanism_detail":"Polyalanine ",
        "Mechanism_source":"(doi.org\/10.1038\/nature05977) (doi.org\/10.1007\/s11604-022-01343-5)",
        "source":"Pathogenic Short Tandem Repeats Gnomad v3.1.2, NBK1423",
        "notes":"There are 3 pathogenic polyalanine tracts in this gene",
        "details":null,
        "width":54.0,
        "OMIM":"140000",
        "Prevalence":null,
        "Prevalence_details":"\"Extremely rare\" (GeneReview)",
        "STRipy_gene":"HOXA13_3",
        "gnomAD_gene":"HOXA13_3",
        "GeneReviews":"NBK1423",
        "Year":2000.0
    },
    {
        "chrom":"chr2",
        "start_hg38":176093058,
        "stop_hg38":176093103,
        "start_hg19":176957786,
        "stop_hg19":176957831,
        "start_t2t":176581179,
        "stop_t2t":176581220,
        "notes_t2t":"(GGC)14.0",
        "id":"SD5_HOXD13",
        "disease_id":"SD5",
        "gene_strand":"+",
        "reference_motif_reference_orientation":"GCN",
        "pathogenic_motif_reference_orientation":"GCN",
        "pathogenic_motif_gene_orientation":"CNG",
        "benign_motif_reference_orientation":null,
        "benign_motif_gene_orientation":"",
        "unknown_motif_reference_orientation":null,
        "unknown_motif_gene_orientation":"",
        "disease":"Syndactyly",
        "gene":"HOXD13",
        "flank_motif":null,
        "locus_structure":"(GCN)*",
        "Inheritance":"AD",
        "type":"Coding",
        "location_in_gene":"Exon 1",
        "normal":"< 15",
        "normal_min":14.0,
        "normal_max":15.0,
        "intermediate":null,
        "intermediate_min":null,
        "intermediate_max":null,
        "pathogenic":">22",
        "pathogenic_min":22.0,
        "pathogenic_max":22.0,
        "ref_copies":14.0,
        "repeatunitlen":3,
        "age_onset":"0 (birth)",
        "age_onset_min":0,
        "age_onset_max":0,
        "typ_age_onset_min":null,
        "typ_age_onset_max":null,
        "novel":"ref",
        "Mechanism":"Polyalanine",
        "Mechanism_detail":"Polyalanine",
        "Mechanism_source":"(doi.org\/10.1038\/nature05977) (doi.org\/10.1007\/s11604-022-01343-5)",
        "source":"Pathogenic Short Tandem Repeats Gnomad v3.1.2, NBK535148",
        "notes":null,
        "details":null,
        "width":45.0,
        "OMIM":"186000",
        "Prevalence":null,
        "Prevalence_details":"3 individuals (GeneReview)",
        "STRipy_gene":"HOXD13",
        "gnomAD_gene":"HOXD13",
        "GeneReviews":"NBK535148",
        "Year":1996.0
    },
    {
        "chrom":"chr4",
        "start_hg38":3074877,
        "stop_hg38":3074940,
        "start_hg19":3076604,
        "stop_hg19":3076667,
        "start_t2t":3073604,
        "stop_t2t":3073694,
        "notes_t2t":"(CAG)30.3",
        "id":"HD_HTT",
        "disease_id":"HD",
        "gene_strand":"+",
        "reference_motif_reference_orientation":"CAG",
        "pathogenic_motif_reference_orientation":"CAG",
        "pathogenic_motif_gene_orientation":"AGC",
        "benign_motif_reference_orientation":null,
        "benign_motif_gene_orientation":"",
        "unknown_motif_reference_orientation":null,
        "unknown_motif_gene_orientation":"",
        "disease":"Huntington disease",
        "gene":"HTT",
        "flank_motif":"(CAG)nCAACAG(CCG)12",
        "locus_structure":"(CAG)*CAACAG(CCG)*",
        "Inheritance":"AD",
        "type":"Coding",
        "location_in_gene":"Exon 1",
        "normal":"6\u201326",
        "normal_min":6.0,
        "normal_max":26.0,
        "intermediate":"27-35 unstable, 36-39 reduced penetrance",
        "intermediate_min":27.0,
        "intermediate_max":39.0,
        "pathogenic":"40\u2013250 (>60 assocated with onset age <20)",
        "pathogenic_min":40.0,
        "pathogenic_max":250.0,
        "ref_copies":21.3,
        "repeatunitlen":3,
        "age_onset":"Typical: 35-44 (GeneReview); Range: 2-85 (PMID: 21171977)",
        "age_onset_min":2,
        "age_onset_max":85,
        "typ_age_onset_min":35.0,
        "typ_age_onset_max":44.0,
        "novel":"ref",
        "Mechanism":"Polyglutamine ",
        "Mechanism_detail":"Polyglutamine ",
        "Mechanism_source":"(doi.org\/10.1038\/nrg.2017.115) (doi.org\/10.1007\/s11604-022-01343-5)",
        "source":"Hannan 2018, Mirkin 2007, GeneReviews, PMID: 12791042",
        "notes":"CAG exp only pathogenic. Interruptions impact pathogenicity (like CAA, PMID: 35245110).",
        "details":null,
        "width":63.0,
        "OMIM":"143100",
        "Prevalence":"1\/10000",
        "Prevalence_details":"Tang et al., 2017: 6.5-15\/100,000; 9.71-17:100,000 (European) vs. 0.1-2\/100,000 (African), as many as 1 in 400 have reduced penetrance (0.2-2% for 36-38 CAG) HTT alleles (GeneReview)",
        "STRipy_gene":"HTT",
        "gnomAD_gene":"HTT",
        "GeneReviews":"NBK1305",
        "Year":1993.0
    },
    {
        "chrom":"chr16",
        "start_hg38":87604283,
        "stop_hg38":87604329,
        "start_hg19":87637889,
        "stop_hg19":87637935,
        "start_t2t":93675724,
        "stop_t2t":93675776,
        "notes_t2t":"(GCT)17.3",
        "id":"HDL2_JPH3",
        "disease_id":"HDL2",
        "gene_strand":"+",
        "reference_motif_reference_orientation":"CTG",
        "pathogenic_motif_reference_orientation":"CTG",
        "pathogenic_motif_gene_orientation":"CTG",
        "benign_motif_reference_orientation":null,
        "benign_motif_gene_orientation":"",
        "unknown_motif_reference_orientation":null,
        "unknown_motif_gene_orientation":"",
        "disease":"Huntington disease-like 2",
        "gene":"JPH3",
        "flank_motif":null,
        "locus_structure":"(CTG)*",
        "Inheritance":"AD",
        "type":"Coding",
        "location_in_gene":"Exon 2",
        "normal":"6\u201328",
        "normal_min":6.0,
        "normal_max":28.0,
        "intermediate":"29-39",
        "intermediate_min":29.0,
        "intermediate_max":39.0,
        "pathogenic":"40\u201358",
        "pathogenic_min":40.0,
        "pathogenic_max":58.0,
        "ref_copies":15.6667,
        "repeatunitlen":3,
        "age_onset":"Typical: 30-52; Range: 12-66 (GeneReview)",
        "age_onset_min":12,
        "age_onset_max":66,
        "typ_age_onset_min":30.0,
        "typ_age_onset_max":52.0,
        "novel":"ref",
        "Mechanism":"LoF/GoF (RNA)",
        "Mechanism_detail":"\"unstable vertical transmission\"",
        "Mechanism_source":"(doi.org\/10.1007\/s11604-022-01343-5), PMID: 38467784",
        "source":"Hannan 2018, Mirkin 2007, GeneReviews NBK1529",
        "notes":"reflen + pos from HipSTR",
        "details":null,
        "width":46.0,
        "OMIM":"606438",
        "Prevalence":null,
        "Prevalence_details":"<1\/1,000,000 (Orphanet); largely in individuals of African descent",
        "STRipy_gene":"JPH3",
        "gnomAD_gene":"JPH3",
        "GeneReviews":"NBK1529",
        "Year":2001.0
    },
    {
        "chrom":"chr8",
        "start_hg38":104588972,
        "stop_hg38":104588999,
        "start_hg19":105601200,
        "stop_hg19":105601227,
        "start_t2t":105716410,
        "stop_t2t":105716441,
        "notes_t2t":"(CGC)10.7",
        "id":"OPDM1_LRP12",
        "disease_id":"OPDM1",
        "gene_strand":"-",
        "reference_motif_reference_orientation":"CGC",
        "pathogenic_motif_reference_orientation":"CGC",
        "pathogenic_motif_gene_orientation":"CGG",
        "benign_motif_reference_orientation":null,
        "benign_motif_gene_orientation":"",
        "unknown_motif_reference_orientation":null,
        "unknown_motif_gene_orientation":"",
        "disease":"Oculopharyngodistal myopathy type 1",
        "gene":"LRP12",
        "flank_motif":null,
        "locus_structure":"(CGC)*",
        "Inheritance":"AD",
        "type":"5' UTR",
        "location_in_gene":null,
        "normal":"13-45",
        "normal_min":13.0,
        "normal_max":45.0,
        "intermediate":null,
        "intermediate_min":null,
        "intermediate_max":null,
        "pathogenic":"90",
        "pathogenic_min":90.0,
        "pathogenic_max":90.0,
        "ref_copies":11.7,
        "repeatunitlen":3,
        "age_onset":"Typical: 31-51 (PMID: 34047774); Range: 7-66 (PMID: 2124290)",
        "age_onset_min":7,
        "age_onset_max":66,
        "typ_age_onset_min":31.0,
        "typ_age_onset_max":51.0,
        "novel":"ref",
        "Mechanism":"RNA toxicity",
        "Mechanism_detail":"RNA mediated toxicity hypothesized; unknown",
        "Mechanism_source":"(OMIM), (doi.org\/10.1007\/s11604-022-01343-5)",
        "source":"OMIM 164310, Ishiura et al [2019], Ehdn, NBK535148, PMID 31332380",
        "notes":"CGG\/CGT; Interruptions Seen: ACG, CCA (PMID: 35245110)",
        "details":"Possible milder clinical phenotype of inherited peripheral neuropathy (IPN) associated with shorter expansions (https://doi.org/10.1212/WNL.000000000020478)",
        "width":27.0,
        "OMIM":"164310",
        "Prevalence":null,
        "Prevalence_details":"Population dependent; unknown percentage of LRP12 pathogenic variants.",
        "STRipy_gene":"LRP12",
        "gnomAD_gene":"LRP12",
        "GeneReviews":"NBK535148",
        "Year":2019.0
    },
    {
        "chrom":"chr5",
        "start_hg38":10356339,
        "stop_hg38":10356411,
        "start_hg19":10356451,
        "stop_hg19":10356523,
        "start_t2t":10295521,
        "stop_t2t":10295593,
        "notes_t2t":"(TTTTA)14.8",
        "id":"FAME3_MARCHF6",
        "disease_id":"FAME3",
        "gene_strand":"+",
        "reference_motif_reference_orientation":"TTTTA",
        "pathogenic_motif_reference_orientation":"TTTCA",
        "pathogenic_motif_gene_orientation":"ATTTC",
        "benign_motif_reference_orientation":null,
        "benign_motif_gene_orientation":"",
        "unknown_motif_reference_orientation":"ATGTT,TAGTT,TTTTG,TTTTT",
        "unknown_motif_gene_orientation":"ATGTT,AGTTT,GTTTT,TTTTT",
        "disease":"Familial adult myoclonic epilepsy type 3",
        "gene":"MARCHF6",
        "flank_motif":null,
        "locus_structure":"(TTTTA)*(TTTCA)*",
        "Inheritance":"AD",
        "type":"Intronic",
        "location_in_gene":"Intron 1",
        "normal":"0",
        "normal_min":null,
        "normal_max":null,
        "intermediate":null,
        "intermediate_min":null,
        "intermediate_max":null,
        "pathogenic":"791-1,035 repeats",
        "pathogenic_min":791.0,
        "pathogenic_max":1035.0,
        "ref_copies":14.8,
        "repeatunitlen":5,
        "age_onset":"Typical: 24-41 (PMID: 19616813; based on one 76 member pedigree); Range: 10 (OMIM) - 46 (PMID: 31664039)",
        "age_onset_min":10,
        "age_onset_max":46,
        "typ_age_onset_min":null,
        "typ_age_onset_max":null,
        "novel":"novel",
        "Mechanism":"Unknown",
        "Mechanism_detail":"Noted as unknown in literature",
        "Mechanism_source":"(OMIM)",
        "source":"Florian, R.T. Nat Comm. 2019",
        "notes":"TTTTA + TTTCA",
        "details":null,
        "width":72.0,
        "OMIM":"613608",
        "Prevalence":null,
        "Prevalence_details":"Overall FAME prevalence is < 1\/35,000; MARCHF6-caused much smaller",
        "STRipy_gene":"MARCHF6",
        "gnomAD_gene":"MARCHF6",
        "GeneReviews":"NBK535148",
        "Year":2019.0
    },
    {
        "chrom":"chr15",
        "start_hg38":22786677,
        "stop_hg38":22786701,
        "start_hg19":23086366,
        "stop_hg19":23086390,
        "start_t2t":20458505,
        "stop_t2t":20458536,
        "notes_t2t":"(GCG)10.7",
        "id":"ALS1_NIPA1",
        "disease_id":"ALS1",
        "gene_strand":"+",
        "reference_motif_reference_orientation":"GCG",
        "pathogenic_motif_reference_orientation":"GCG",
        "pathogenic_motif_gene_orientation":"CGG",
        "benign_motif_reference_orientation":null,
        "benign_motif_gene_orientation":"",
        "unknown_motif_reference_orientation":null,
        "unknown_motif_gene_orientation":"",
        "disease":"Amyotrophic lateral sclerosis",
        "gene":"NIPA1",
        "flank_motif":null,
        "locus_structure":"(GCG)*",
        "Inheritance":"AD",
        "type":"Coding",
        "location_in_gene":null,
        "normal":"6-10",
        "normal_min":6.0,
        "normal_max":10.0,
        "intermediate":null,
        "intermediate_min":null,
        "intermediate_max":null,
        "pathogenic":"> 11",
        "pathogenic_min":11.0,
        "pathogenic_max":56.0,
        "ref_copies":10.7,
        "repeatunitlen":3,
        "age_onset":"Typical: 44-60 (PMID: 26777436); Range: 25 (PMID: 22378146) - 77 (PMID: 26777436)",
        "age_onset_min":25,
        "age_onset_max":77,
        "typ_age_onset_min":44.0,
        "typ_age_onset_max":60.0,
        "novel":"ref",
        "Mechanism":null,
        "Mechanism_detail":"No information found",
        "Mechanism_source":"N\/A in GeneCard",
        "source":"Pathogenic Short Tandem Repeats Gnomad v3.1.2, 30342764 (Pubmed), path range from gnomAD",
        "notes":"Proposed modifier for ALS",
        "details":null,
        "width":24.0,
        "OMIM":"105400",
        "Prevalence":null,
        "Prevalence_details":"2.7-7.4\/100,000 (All ALS, not just this locus), NIPA1 + C9orf72 is 0.37% of ALS patients; frequency of NIPA1 expansion in controls is 3.74% (PMID: 31286297)",
        "STRipy_gene":"NIPA1",
        "gnomAD_gene":"NIPA1",
        "GeneReviews":null,
        "Year":null
    },
    {
        "chrom":"chr20",
        "start_hg38":2652733,
        "stop_hg38":2652757,
        "start_hg19":2633379,
        "stop_hg19":2633403,
        "start_t2t":2683200,
        "stop_t2t":2683224,
        "notes_t2t":"(GCCTGG)8.8",
        "id":"SCA36_NOP56",
        "disease_id":"SCA36",
        "gene_strand":"+",
        "reference_motif_reference_orientation":"GGCCTG",
        "pathogenic_motif_reference_orientation":"GGCCTG",
        "pathogenic_motif_gene_orientation":"CCTGGG",
        "benign_motif_reference_orientation":null,
        "benign_motif_gene_orientation":"",
        "unknown_motif_reference_orientation":null,
        "unknown_motif_gene_orientation":"",
        "disease":"Spinocerebellar ataxia type 36",
        "gene":"NOP56",
        "flank_motif":"(GGCCTG)n(CGCCTG)3",
        "locus_structure":"(GGCCTG)*(CGCCTG)*",
        "Inheritance":"AD",
        "type":"Intronic",
        "location_in_gene":"Intron 1",
        "normal":"3 to 14",
        "normal_min":3.0,
        "normal_max":14.0,
        "intermediate":"15-649",
        "intermediate_min":15.0,
        "intermediate_max":649.0,
        "pathogenic":"650-2500",
        "pathogenic_min":650.0,
        "pathogenic_max":2500.0,
        "ref_copies":7.2,
        "repeatunitlen":6,
        "age_onset":"Typical: 40-60 (NBK231880); Range: 28 (PMID: 37810464) - 67 (PMID: 37332636)",
        "age_onset_min":28,
        "age_onset_max":67,
        "typ_age_onset_min":40.0,
        "typ_age_onset_max":60.0,
        "novel":"ref",
        "Mechanism":"Protein toxic GOF",
        "Mechanism_detail":"toxic gain-of-function mechanism",
        "Mechanism_source":"(OMIM)",
        "source":"GeneReviews, OMIM, NBK231880",
        "notes":"Interruptions: GGCTG, GGCCCTG, GGCCG, and GGCCTTG (PMID: 37051597)",
        "details":null,
        "width":42.0,
        "OMIM":"614153",
        "Prevalence":null,
        "Prevalence_details":"Western Japan: 3.6% of all SCA; Costa da Morte region of Spain: 6.3% of all SCA(PMID: 37332636); US: 0.7% of large undiagnosed ataxia cohort (PMID: 28761930)",
        "STRipy_gene":"NOP56",
        "gnomAD_gene":"NOP56",
        "GeneReviews":null,
        "Year":2011.0
    },
    {
        "chrom":"chr1",
        "start_hg38":149390803,
        "stop_hg38":149390842,
        "start_hg19":145209324,
        "stop_hg19":145209354,
        "start_t2t":148519696,
        "stop_t2t":148519738,
        "notes_t2t":"(GGC)14.3",
        "id":"NIID_NOTCH2NLC",
        "disease_id":"NIID",
        "gene_strand":"+",
        "reference_motif_reference_orientation":"GGC",
        "pathogenic_motif_reference_orientation":"GGC",
        "pathogenic_motif_gene_orientation":"CGG",
        "benign_motif_reference_orientation":null,
        "benign_motif_gene_orientation":"",
        "unknown_motif_reference_orientation":null,
        "unknown_motif_gene_orientation":"",
        "disease":"Neuronal intranuclear inclusion disease, Alzheimer disease and parkinsonism phenotype",
        "gene":"NOTCH2NLC",
        "flank_motif":null,
        "locus_structure":"(GGC)*",
        "Inheritance":"AD",
        "type":"5' UTR",
        "location_in_gene":"5' Region",
        "normal":"7\u201339",
        "normal_min":7.0,
        "normal_max":39.0,
        "intermediate":null,
        "intermediate_min":null,
        "intermediate_max":null,
        "pathogenic":"66-517",
        "pathogenic_min":66.0,
        "pathogenic_max":517.0,
        "ref_copies":13.3,
        "repeatunitlen":3,
        "age_onset":"Typical: 30-70 (OMIM); Range: 10 (PMID: 37090934) - 78 (PMID: 37305750)",
        "age_onset_min":10,
        "age_onset_max":78,
        "typ_age_onset_min":30.0,
        "typ_age_onset_max":70.0,
        "novel":"ref",
        "Mechanism":"PolyG/RNA GoF",
        "Mechanism_detail":"May relate to methylation or RNA pathogenicity",
        "Mechanism_source":"(OMIM) (doi.org\/10.1007\/s11604-022-01343-5), PMID: 38467784",
        "source":"doi: 10.1038\/s41588-019-0458-z, https:\/\/doi.org\/10.1016\/j.ajhg.2019.05.013, s40478-021-01201-x",
        "notes":"May be issues with parology between genes: C253572.1, NOTCH2, NOTCH2NL, NBPF14, NBPF19 ?? Motif variation in controls: (AGG)(CGG)n(AGG)0-3(CGG)0-2. Methylation involved. GGA and AGC interruptions may influence phenotype (PMID: 34718964); Interruptions Seen: GGA, GGG (PMID: 35245110); ACCGAGAAGATGCCCGCCCTGC interruption mentioned but not confirmed in PMID: 38467784",
        "details":"Age of onset inversely related to allele size (PMID: 38377026)",
        "width":39.0,
        "OMIM":"603472",
        "Prevalence":null,
        "Prevalence_details":">400 patients reported in literature (PMID: 37371433)",
        "STRipy_gene":"NOTCH2NLC",
        "gnomAD_gene":"NOTCH2NLC",
        "GeneReviews":"NBK535148",
        "Year":2019.0
    },
    {
        "chrom":"chr10",
        "start_hg38":79826383,
        "stop_hg38":79826404,
        "start_hg19":81586139,
        "stop_hg19":81586160,
        "start_t2t":80695712,
        "stop_t2t":80695748,
        "notes_t2t":"(GCG)12.7",
        "id":"OPML1_NUTM2B-AS1",
        "disease_id":"OPML1",
        "gene_strand":"+",
        "reference_motif_reference_orientation":"GGC",
        "pathogenic_motif_reference_orientation":"GGC",
        "pathogenic_motif_gene_orientation":"CGG",
        "benign_motif_reference_orientation":null,
        "benign_motif_gene_orientation":"",
        "unknown_motif_reference_orientation":null,
        "unknown_motif_gene_orientation":"",
        "disease":"Oculopharyngeal myopathy with leukoencephalopathy 1",
        "gene":"NUTM2B-AS1",
        "flank_motif":null,
        "locus_structure":"(GGC)*",
        "Inheritance":"AD",
        "type":"lncRNA",
        "location_in_gene":"Exon 1 (noncoding)",
        "normal":"3-16",
        "normal_min":3.0,
        "normal_max":16.0,
        "intermediate":null,
        "intermediate_min":null,
        "intermediate_max":null,
        "pathogenic":">700",
        "pathogenic_min":700.0,
        "pathogenic_max":700.0,
        "ref_copies":7.0,
        "repeatunitlen":3,
        "age_onset":"15-40 (PMID: 31332380; only characterized in one family)",
        "age_onset_min":15,
        "age_onset_max":40,
        "typ_age_onset_min":null,
        "typ_age_onset_max":null,
        "novel":"ref",
        "Mechanism":"RNA toxicity",
        "Mechanism_detail":"RNA mediated toxicity hypothesized, unknown",
        "Mechanism_source":"(OMIM) (doi.org\/10.1007\/s11604-022-01343-5)",
        "source":"Pathogenic Short Tandem Repeats Gnomad v3.1.2, Ishiura 2019, doi: 10.1038\/s41588-019-0458-z, https:\/\/doi.org\/10.1038\/s41580-021-00382-6",
        "notes":"Not in TRF annotation, alt transcript in opposite direction: LOC642361",
        "details":null,
        "width":21.0,
        "OMIM":"618637",
        "Prevalence":null,
        "Prevalence_details":"\"Rare\"",
        "STRipy_gene":"NUTM2B-AS1",
        "gnomAD_gene":"NUTM2B-AS1",
        "GeneReviews":"NBK535148",
        "Year":2019.0
    },
    {
        "chrom":"chr14",
        "start_hg38":23321472,
        "stop_hg38":23321502,
        "start_hg19":23790681,
        "stop_hg19":23790711,
        "start_t2t":17522488,
        "stop_t2t":17522518,
        "notes_t2t":null,
        "id":"OPMD_PABPN1",
        "disease_id":"OPMD",
        "gene_strand":"+",
        "reference_motif_reference_orientation":"GCN",
        "pathogenic_motif_reference_orientation":"GCN",
        "pathogenic_motif_gene_orientation":"CNG",
        "benign_motif_reference_orientation":null,
        "benign_motif_gene_orientation":"",
        "unknown_motif_reference_orientation":null,
        "unknown_motif_gene_orientation":"",
        "disease":"Oculopharyngeal muscular dystrophy",
        "gene":"PABPN1",
        "flank_motif":null,
        "locus_structure":"(GCN)*",
        "Inheritance":"AD\/AR",
        "type":"Coding",
        "location_in_gene":"Exon 1",
        "normal":"10",
        "normal_min":10.0,
        "normal_max":10.0,
        "intermediate":null,
        "intermediate_min":null,
        "intermediate_max":null,
        "pathogenic":"12-17",
        "pathogenic_min":12.0,
        "pathogenic_max":17.0,
        "ref_copies":7.0,
        "repeatunitlen":3,
        "age_onset":"Typical: 40-59 (PMID: 37519616); Range: 20-79 (PMID: 35112761)",
        "age_onset_min":20,
        "age_onset_max":79,
        "typ_age_onset_min":40.0,
        "typ_age_onset_max":59.0,
        "novel":"ref",
        "Mechanism":"Polyalanine ",
        "Mechanism_detail":"Polyalanine ",
        "Mechanism_source":"(doi.org\/10.1038\/nrg.2017.115) (doi.org\/10.1007\/s11604-022-01343-5)",
        "source":"Mirkin 2007, GeneReviews NBK1126, s40478-021-01201-x",
        "notes":"AR for 11 repeats, AD >12 repeats. Most known patients have (GCG)+, but GCN or any polyalanine may be pathogenic",
        "details":null,
        "width":20.0,
        "OMIM":"164300",
        "Prevalence":"1\/100000",
        "Prevalence_details":"Tang et al., 2017: 1\/100,000; population specific; frequency of GCN[11] alleles is 1-2% of North America\/Europe\/Japan (GeneReview)",
        "STRipy_gene":"PABPN1",
        "gnomAD_gene":"PABPN1",
        "GeneReviews":"NBK1126",
        "Year":1998.0
    },
    {
        "chrom":"chr4",
        "start_hg38":41745972,
        "stop_hg38":41746032,
        "start_hg19":41747989,
        "stop_hg19":41748049,
        "start_t2t":41719745,
        "stop_t2t":41719805,
        "notes_t2t":"(GCC)15.7",
        "id":"CCHS_PHOX2B",
        "disease_id":"CCHS",
        "gene_strand":"-",
        "reference_motif_reference_orientation":"GCN",
        "pathogenic_motif_reference_orientation":"GCN",
        "pathogenic_motif_gene_orientation":"CNG",
        "benign_motif_reference_orientation":null,
        "benign_motif_gene_orientation":"",
        "unknown_motif_reference_orientation":null,
        "unknown_motif_gene_orientation":"",
        "disease":"Congenital central hypoventilation syndrome",
        "gene":"PHOX2B",
        "flank_motif":null,
        "locus_structure":"(GCN)*",
        "Inheritance":"AD",
        "type":"Coding",
        "location_in_gene":"Exon 3",
        "normal":"20",
        "normal_min":15.0,
        "normal_max":20.0,
        "intermediate":"24",
        "intermediate_min":24.0,
        "intermediate_max":24.0,
        "pathogenic":"25-33",
        "pathogenic_min":25.0,
        "pathogenic_max":33.0,
        "ref_copies":15.7,
        "repeatunitlen":3,
        "age_onset":"Typical: 0-2 (GeneReview\/PMID: 15121777); Range: 0-36 (PMID: 16873766)",
        "age_onset_min":0,
        "age_onset_max":36,
        "typ_age_onset_min":0.0,
        "typ_age_onset_max":2.0,
        "novel":"ref",
        "Mechanism":"Polyalanine",
        "Mechanism_detail":"Polyalanine",
        "Mechanism_source":"(doi.org\/10.1038\/nature05977) (doi.org\/10.1007\/s11604-022-01343-5)",
        "source":"Mirkin 2007, GeneReviews NBK1427, s40478-021-01201-x",
        "notes":"ReferenceRegion: 4:41745971-41746032",
        "details":null,
        "width":46.0,
        "OMIM":"209880",
        "Prevalence":null,
        "Prevalence_details":"Incidence is 1:148000-200000 births (Estimated, may include mild\/undiagnosed or be overestimate globally) (GeneReview)",
        "STRipy_gene":"PHOX2B",
        "gnomAD_gene":"PHOX2B",
        "GeneReviews":"NBK1427",
        "Year":2003.0
    },
    {
        "chrom":"chr15",
        "start_hg38":89333589,
        "stop_hg38":89333629,
        "start_hg19":89876820,
        "stop_hg19":89876860,
        "start_t2t":87088412,
        "stop_t2t":87088452,
        "notes_t2t":"(GCT)13.7",
        "id":"CPEO_POLG",
        "disease_id":"CPEO",
        "gene_strand":"-",
        "reference_motif_reference_orientation":"GCT",
        "pathogenic_motif_reference_orientation":"GCT",
        "pathogenic_motif_gene_orientation":"AGC",
        "benign_motif_reference_orientation":null,
        "benign_motif_gene_orientation":"",
        "unknown_motif_reference_orientation":null,
        "unknown_motif_gene_orientation":"",
        "disease":"Progressive external ophthalmoplegia, Parkinson\u2019s disease",
        "gene":"POLG",
        "flank_motif":null,
        "locus_structure":"(CTG)*TTG(CTG)*",
        "Inheritance":null,
        "type":"Coding",
        "location_in_gene":null,
        "normal":"10",
        "normal_min":10.0,
        "normal_max":10.0,
        "intermediate":null,
        "intermediate_min":null,
        "intermediate_max":null,
        "pathogenic":"Deviation from 10 may impart disease risk with variable penetrance",
        "pathogenic_min":null,
        "pathogenic_max":null,
        "ref_copies":13.7,
        "repeatunitlen":3,
        "age_onset":"Typical: 57 (PMID: 20399836) - 59 (PMID: 20826197); Range: 23-87 (PMID: 20399836)",
        "age_onset_min":23,
        "age_onset_max":87,
        "typ_age_onset_min":57.0,
        "typ_age_onset_max":59.0,
        "novel":"ref",
        "Mechanism":null,
        "Mechanism_detail":"No information found",
        "Mechanism_source":"N\/A in GeneCard",
        "source":"PMC2905783, PMID: 20399836, PMID: 10196696",
        "notes":"Unconfirmed association",
        "details":"There is conflicting evidence for the association between this repeat expansion and Parkinson's risk (PMID: 20399836 and PMID: 10196696). Deviation from 10 may impart disease risk with variable penetrance. May be predisposing factor in earlier age of onset in FRDA patients (PMID: 19043662)",
        "width":40.0,
        "OMIM":"Disease association unclear",
        "Prevalence":null,
        "Prevalence_details":"Unknown",
        "STRipy_gene":null,
        "gnomAD_gene":null,
        "GeneReviews":null,
        "Year":null
    },
    {
        "chrom":"chr5",
        "start_hg38":146878728,
        "stop_hg38":146878759,
        "start_hg19":146258291,
        "stop_hg19":146258322,
        "start_t2t":147414734,
        "stop_t2t":147414765,
        "notes_t2t":"(GCT)15.7",
        "id":"SCA12_PPP2R2B",
        "disease_id":"SCA12",
        "gene_strand":"-",
        "reference_motif_reference_orientation":"GCT",
        "pathogenic_motif_reference_orientation":"GCT",
        "pathogenic_motif_gene_orientation":"AGC",
        "benign_motif_reference_orientation":null,
        "benign_motif_gene_orientation":"",
        "unknown_motif_reference_orientation":null,
        "unknown_motif_gene_orientation":"",
        "disease":"Spinocerebellar ataxia type 12",
        "gene":"PPP2R2B",
        "flank_motif":null,
        "locus_structure":"(GCT)*",
        "Inheritance":"AD",
        "type":"Promoter",
        "location_in_gene":null,
        "normal":"4\u201332",
        "normal_min":4.0,
        "normal_max":32.0,
        "intermediate":null,
        "intermediate_min":null,
        "intermediate_max":null,
        "pathogenic":"51\u201378",
        "pathogenic_min":51.0,
        "pathogenic_max":78.0,
        "ref_copies":10.7,
        "repeatunitlen":3,
        "age_onset":"Typical: 26-50; Range: 8-56 (OMIM)",
        "age_onset_min":8,
        "age_onset_max":62,
        "typ_age_onset_min":26.0,
        "typ_age_onset_max":50.0,
        "novel":"ref",
        "Mechanism":"GoF Polyalanine, RAN translation",
        "Mechanism_detail":"GoF (PolyA), RAN translation",
        "Mechanism_source":"PMID: 38467784",
        "source":"Hannan 2018, Mirkin 2007, OMIM, NBK535148, s40478-021-01201-x",
        "notes":"(Roda et al. suggested that the ATXN8 or ATXN8OS gene should not be evaluated in isolation as a candidate gene for spinocerebellar degenerative disease)",
        "details":null,
        "width":31.0,
        "OMIM":"604326",
        "Prevalence":null,
        "Prevalence_details":"Unknown. Frequent in India; rare in other places (PMID: 34711523)",
        "STRipy_gene":"PPP2R2B",
        "gnomAD_gene":"PPP2R2B",
        "GeneReviews":"NBK535148",
        "Year":1999.0
    },
    {
        "chrom":"chr9",
        "start_hg38":130681606,
        "stop_hg38":130681639,
        "start_hg19":133556993,
        "stop_hg19":133557026,
        "start_t2t":142886569,
        "stop_t2t":142886595,
        "notes_t2t":"(CGC)9.0",
        "id":"HSAN-VIII_PRDM12",
        "disease_id":"HSAN VIII",
        "gene_strand":"+",
        "reference_motif_reference_orientation":"GCC",
        "pathogenic_motif_reference_orientation":"GCC",
        "pathogenic_motif_gene_orientation":"CCG",
        "benign_motif_reference_orientation":null,
        "benign_motif_gene_orientation":"",
        "unknown_motif_reference_orientation":null,
        "unknown_motif_gene_orientation":"",
        "disease":"Hereditary sensory and autonomic neuropathy type VIII",
        "gene":"PRDM12",
        "flank_motif":null,
        "locus_structure":"(GCC)*",
        "Inheritance":"AR",
        "type":"Coding",
        "location_in_gene":"Exon",
        "normal":"<14",
        "normal_min":12.0,
        "normal_max":14.0,
        "intermediate":null,
        "intermediate_min":null,
        "intermediate_max":null,
        "pathogenic":">18",
        "pathogenic_min":18.0,
        "pathogenic_max":19.0,
        "ref_copies":12.0,
        "repeatunitlen":3,
        "age_onset":"0 (birth)",
        "age_onset_min":0,
        "age_onset_max":0,
        "typ_age_onset_min":null,
        "typ_age_onset_max":null,
        "novel":"ref",
        "Mechanism":"LOF, epigenetic",
        "Mechanism_detail":"\"mutations abrogated the histone-modifying potential of PRDM12, consistent with a loss of function\"",
        "Mechanism_source":"OMIM",
        "source":"Pathogenic Short Tandem Repeats Gnomad v3.1.2, https:\/\/doi.org\/10.1038\/ng.3308",
        "notes":null,
        "details":null,
        "width":33.0,
        "OMIM":"616488",
        "Prevalence":null,
        "Prevalence_details":"Found in 2 families. All PRDM12 disease mutations < 1\/1,000,000",
        "STRipy_gene":"PRDM12",
        "gnomAD_gene":"PRDM12",
        "GeneReviews":"NBK535148",
        "Year":null
    },
    {
        "chrom":"chr20",
        "start_hg38":4699397,
        "stop_hg38":4699493,
        "start_hg19":4680043,
        "stop_hg19":4680139,
        "start_t2t":4738633,
        "stop_t2t":4738705,
        "notes_t2t":null,
        "id":"CJD_PRNP",
        "disease_id":"CJD",
        "gene_strand":"+",
        "reference_motif_reference_orientation":"GGTGGTGGCTGGGGGCAGCCTCAT",
        "pathogenic_motif_reference_orientation":"CCTCATGGTGGTGGCTGGGGGCAG",
        "pathogenic_motif_gene_orientation":"AGCCTCATGGTGGTGGCTGGGGGC",
        "benign_motif_reference_orientation":null,
        "benign_motif_gene_orientation":"",
        "unknown_motif_reference_orientation":null,
        "unknown_motif_gene_orientation":"",
        "disease":"Creutzfeldt-Jakob disease",
        "gene":"PRNP",
        "flank_motif":"(CCTCAGGGCGGTGGTGGCTGGGGGCAG)1(CCTCATGGTGGTGGCTGGGGGCAG)n",
        "locus_structure":"(CCTCAGGGCGGTGGTGGCTGGGGGCAG)*(CCTCATGGTGGTGGCTGGGGGCAG)*",
        "Inheritance":"AD",
        "type":"Coding",
        "location_in_gene":"Exon 2",
        "normal":"<=4",
        "normal_min":null,
        "normal_max":4.0,
        "intermediate":null,
        "intermediate_min":null,
        "intermediate_max":null,
        "pathogenic":">=5",
        "pathogenic_min":5.0,
        "pathogenic_max":null,
        "ref_copies":null,
        "repeatunitlen":24,
        "age_onset":"Typical: 50-60 (GeneReview); Range: 31-63 (PMID: 37379724)",
        "age_onset_min":31,
        "age_onset_max":63,
        "typ_age_onset_min":50.0,
        "typ_age_onset_max":60.0,
        "novel":null,
        "Mechanism":null,
        "Mechanism_detail":null,
        "Mechanism_source":null,
        "source":"https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK1229\/",
        "notes":null,
        "details":null,
        "width":null,
        "OMIM":"123400",
        "Prevalence":null,
        "Prevalence_details":"<0.0225\/1,000,000: <15% of CJ variants are repeat expansions (NBK535148). 15% newly diagnosed prion disease cases are genetic (GeneReview) 1 individual per million per year worldwide (350 cases annually in US) (PMID: 29939637)",
        "STRipy_gene":null,
        "gnomAD_gene":"PRNP",
        "GeneReviews":"NBK1229",
        "Year":null
    },
    {
        "chrom":"chr4",
        "start_hg38":159342527,
        "stop_hg38":159342618,
        "start_hg19":160263679,
        "stop_hg19":160263770,
        "start_t2t":162693304,
        "stop_t2t":162693405,
        "notes_t2t":"(TTTTA)20.4",
        "id":"FAME7_RAPGEF2",
        "disease_id":"FAME7",
        "gene_strand":"+",
        "reference_motif_reference_orientation":"TTTTA",
        "pathogenic_motif_reference_orientation":"TTTCA",
        "pathogenic_motif_gene_orientation":"ATTTC",
        "benign_motif_reference_orientation":null,
        "benign_motif_gene_orientation":"",
        "unknown_motif_reference_orientation":"TTTTT,TTATG",
        "unknown_motif_gene_orientation":"TTTTT,ATGTT",
        "disease":"Familial adult myoclonic epilepsy type 7",
        "gene":"RAPGEF2",
        "flank_motif":null,
        "locus_structure":"(TTTTA)*(TTTCA)*(TTTTA)*",
        "Inheritance":"AD",
        "type":"Intronic",
        "location_in_gene":"Intron 14",
        "normal":"0-1",
        "normal_min":0.0,
        "normal_max":1.0,
        "intermediate":null,
        "intermediate_min":null,
        "intermediate_max":null,
        "pathogenic":">=60",
        "pathogenic_min":60.0,
        "pathogenic_max":60.0,
        "ref_copies":17.4,
        "repeatunitlen":5,
        "age_onset":"Typical: 20-33 (PMID: 30351492); Range: 18 (PMID: 29507423) - 37 (PMID: 30351492)",
        "age_onset_min":18,
        "age_onset_max":37,
        "typ_age_onset_min":null,
        "typ_age_onset_max":null,
        "novel":"novel",
        "Mechanism":"RNA toxicity",
        "Mechanism_detail":"RNA toxicity hypothesized",
        "Mechanism_source":"(10.1038\/s41588-018-0067-2)",
        "source":"Ishiura 2018, 29507423 (Pubmed), https:\/\/sci-hub.hkvisa.net\/10.1111\/ene.13848",
        "notes":"Novel, (TTTTA)exp(TTTCA)exp(TTTTA)n, but only the TTTCA is specific to affected individuals, Alu-associated repeat, incomplete penetrance. Interruptions Seen: TATTA, TTTTTA (PMID: 35245110)",
        "details":null,
        "width":91.0,
        "OMIM":"618075",
        "Prevalence":null,
        "Prevalence_details":"FAME overall is 1\/35,000 in Japan",
        "STRipy_gene":"RAPGEF2",
        "gnomAD_gene":"RAPGEF2",
        "GeneReviews":"NBK535148",
        "Year":2018.0
    },
    {
        "chrom":"chr4",
        "start_hg38":39348425,
        "stop_hg38":39348483,
        "start_hg19":39350045,
        "stop_hg19":39350103,
        "start_t2t":39318078,
        "stop_t2t":39318136,
        "notes_t2t":"(AAAAG)11.8",
        "id":"CANVAS_RFC1",
        "disease_id":"CANVAS",
        "gene_strand":"-",
        "reference_motif_reference_orientation":"AAAAG",
        "pathogenic_motif_reference_orientation":"AAGGG,ACAGG,AGGGC,AAGGC,AGAGG",
        "pathogenic_motif_gene_orientation":"CCCTT,CCTGT,CCCTG,CCTTG,CCTCT",
        "benign_motif_reference_orientation":"AAAAG,AAAGG,AAGAG",
        "benign_motif_gene_orientation":"CTTTT,CCTTT,CTCTT",
        "unknown_motif_reference_orientation":"AAAAA,AAAAC,AACGG,AAGAC,AAGGT,AGAAC,AGGGG,GAAAC,GGGAC,GTGAG,AAAAGA,AAAGGA,GGAAAG",
        "unknown_motif_gene_orientation":"TTTTT,GTTTT,CCGTT,CTTGT,ACCTT,CTGTT,CCCCT,CGTTT,CCCGT,ACCTC,CTTTTT,CCTTTT,CCCTTT",
        "disease":"Cerebellar ataxia, neuropathy, and vestibular areflexia syndrome",
        "gene":"RFC1",
        "flank_motif":null,
        "locus_structure":"(AAGGG)*(ACAGG)*",
        "Inheritance":"AR",
        "type":"Intronic",
        "location_in_gene":"Intron 2",
        "normal":"0-11",
        "normal_min":0.0,
        "normal_max":11.0,
        "intermediate":null,
        "intermediate_min":null,
        "intermediate_max":null,
        "pathogenic":">400",
        "pathogenic_min":400.0,
        "pathogenic_max":2000.0,
        "ref_copies":11.8,
        "repeatunitlen":5,
        "age_onset":"Typical: 36-52; Range: 19-76 (GeneReviews)",
        "age_onset_min":19,
        "age_onset_max":76,
        "typ_age_onset_min":36.0,
        "typ_age_onset_max":52.0,
        "novel":"novel",
        "Mechanism":"LoF",
        "Mechanism_detail":"LoF",
        "Mechanism_source":"PMID: 38467784",
        "source":"OMIM, Cortese 2019, 30926972 (Pubmed), https:\/\/actaneurocomms.biomedcentral.com\/articles\/10.1186\/s40478-021-01201-x\/tables\/1, s40478-021-01201-x, https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK564656\/, https:\/\/doi.org\/10.1101\/2023.05.12.540470",
        "notes":"Novel, ref is AAAAG(11), path: (AAGGG)400\u20132000 or (ACAGG)exp",
        "details":"Pathogenic expansions may be flanked by other motifs. For example, (AAAGG)10-25(AAGGG)exp(AAAGG)4-6 (PMID: 32851396). Motif heterogeneity is common in unaffected individuals. The pathogenic size threshold appears to differ for the AAAGG motif. AAAGG expansions >= 600 repeats have been observed in CANVAS patients, while ~100-380 repeats have been observed in controls, and so are not predicted to be pathogenic (PMID: 37450567).",
        "width":58.0,
        "OMIM":"614575",
        "Prevalence":null,
        "Prevalence_details":"Carrier frequency in European is 0.7-4% and in Chinese Han population is 2.24%; estimated prevalence of 1\/20,000 to 1\/625 (GeneReview)",
        "STRipy_gene":"RFC1",
        "gnomAD_gene":"RFC1",
        "GeneReviews":"NBK564656",
        "Year":2019.0
    },
    {
        "chrom":"chr12",
        "start_hg38":123533720,
        "stop_hg38":123533755,
        "start_hg19":124018267,
        "stop_hg19":124018302,
        "start_t2t":123532574,
        "stop_t2t":123532608,
        "notes_t2t":"(GGC)11.7",
        "id":"OPDM4_RILPL1",
        "disease_id":"OPDM4",
        "gene_strand":"-",
        "reference_motif_reference_orientation":"GGC",
        "pathogenic_motif_reference_orientation":"GGC",
        "pathogenic_motif_gene_orientation":"CCG",
        "benign_motif_reference_orientation":null,
        "benign_motif_gene_orientation":"",
        "unknown_motif_reference_orientation":null,
        "unknown_motif_gene_orientation":"",
        "disease":"Oculopharyngodistal myopathy type 4",
        "gene":"RILPL1",
        "flank_motif":null,
        "locus_structure":"(GGC)*",
        "Inheritance":"AD",
        "type":"5' UTR",
        "location_in_gene":null,
        "normal":"9-16",
        "normal_min":9.0,
        "normal_max":16.0,
        "intermediate":null,
        "intermediate_min":null,
        "intermediate_max":null,
        "pathogenic":"139 to 197",
        "pathogenic_min":139.0,
        "pathogenic_max":197.0,
        "ref_copies":11.7,
        "repeatunitlen":3,
        "age_onset":"Typical: 18-30 (PMID: 35148830); Range: 10-30 (PMID: 35700120)",
        "age_onset_min":10,
        "age_onset_max":30,
        "typ_age_onset_min":18.0,
        "typ_age_onset_max":30.0,
        "novel":"ref",
        "Mechanism":"Protein toxic GOF",
        "Mechanism_detail":"toxic gain-of-function mechanism ",
        "Mechanism_source":"(Malacard)",
        "source":"Yu 2022 AJHG",
        "notes":"toxic poly-glycine protein and\/or toxic RNA gain-of-function effects. AGG and TGG interruptions (PMID: 35148830)",
        "details":null,
        "width":35.0,
        "OMIM":null,
        "Prevalence":null,
        "Prevalence_details":"Population dependent. 21.6% of one OPDM cohort (PMID: 35148830)",
        "STRipy_gene":"RILPL1",
        "gnomAD_gene":null,
        "GeneReviews":null,
        "Year":2022.0
    },
    {
        "chrom":"chr6",
        "start_hg38":45422750,
        "stop_hg38":45422792,
        "start_hg19":45390487,
        "stop_hg19":45390529,
        "start_t2t":45257567,
        "stop_t2t":45257611,
        "notes_t2t":"(GGC)15.0",
        "id":"CCD_RUNX2",
        "disease_id":"CCD",
        "gene_strand":"+",
        "reference_motif_reference_orientation":"GCN",
        "pathogenic_motif_reference_orientation":"GCN",
        "pathogenic_motif_gene_orientation":"CNG",
        "benign_motif_reference_orientation":null,
        "benign_motif_gene_orientation":"",
        "unknown_motif_reference_orientation":null,
        "unknown_motif_gene_orientation":"",
        "disease":"Cleidocranial dysplasia",
        "gene":"RUNX2",
        "flank_motif":null,
        "locus_structure":"(GCN)*",
        "Inheritance":"AD",
        "type":"Coding",
        "location_in_gene":"Exon 3",
        "normal":"<17",
        "normal_min":4.0,
        "normal_max":17.0,
        "intermediate":null,
        "intermediate_min":null,
        "intermediate_max":null,
        "pathogenic":">27",
        "pathogenic_min":27.0,
        "pathogenic_max":27.0,
        "ref_copies":15.0,
        "repeatunitlen":3,
        "age_onset":"0 (birth) (GeneReviews)",
        "age_onset_min":0,
        "age_onset_max":0,
        "typ_age_onset_min":null,
        "typ_age_onset_max":null,
        "novel":"ref",
        "Mechanism":"Polyalanine",
        "Mechanism_detail":"Polyalanine",
        "Mechanism_source":"(doi.org\/10.1038\/nature05977) (doi.org\/10.1007\/s11604-022-01343-5)",
        "source":"Pathogenic Short Tandem Repeats Gnomad v3.1.2, NBK535148",
        "notes":null,
        "details":null,
        "width":42.0,
        "OMIM":"119600",
        "Prevalence":null,
        "Prevalence_details":"All conditions 1\/1,000,000 births (likely underdiagnosed); Utah population frequency 0.12\/10,000",
        "STRipy_gene":"RUNX2",
        "gnomAD_gene":"RUNX2",
        "GeneReviews":"NBK1513",
        "Year":1997.0
    },
    {
        "chrom":"chr8",
        "start_hg38":118366813,
        "stop_hg38":118366918,
        "start_hg19":119379052,
        "stop_hg19":119379157,
        "start_t2t":119495248,
        "stop_t2t":119495353,
        "notes_t2t":"(AAATA)21.6",
        "id":"FAME1_SAMD12",
        "disease_id":"FAME1",
        "gene_strand":"-",
        "reference_motif_reference_orientation":"TAAAA",
        "pathogenic_motif_reference_orientation":"TGAAA",
        "pathogenic_motif_gene_orientation":"ATTTC",
        "benign_motif_reference_orientation":null,
        "benign_motif_gene_orientation":"",
        "unknown_motif_reference_orientation":"AAAAA,TAAAC,TAACA,TACAA,TACAC",
        "unknown_motif_gene_orientation":"TTTTT,AGTTT,ATGTT,ATTGT,AGTGT",
        "disease":"Familial adult myoclonic epilepsy type 1",
        "gene":"SAMD12",
        "flank_motif":null,
        "locus_structure":"(TAAAA)*(TGAAA)*(TAAAA)*",
        "Inheritance":"AD",
        "type":"Intronic",
        "location_in_gene":"Intron 4\/4",
        "normal":"0",
        "normal_min":0.0,
        "normal_max":0.0,
        "intermediate":null,
        "intermediate_min":null,
        "intermediate_max":null,
        "pathogenic":"105\u20133680",
        "pathogenic_min":105.0,
        "pathogenic_max":3680.0,
        "ref_copies":21.6,
        "repeatunitlen":5,
        "age_onset":"Typical: 21-39 (PMID: 29939203); Range: 12 (PMID: 29939203) - 68 (PMID: 29507423)",
        "age_onset_min":12,
        "age_onset_max":68,
        "typ_age_onset_min":21.0,
        "typ_age_onset_max":39.0,
        "novel":"novel",
        "Mechanism":"RNA toxicity proposed",
        "Mechanism_detail":"RNA molecules",
        "Mechanism_source":"(OMIM)",
        "source":"Ishiura 2018. https:\/\/movementdisorders.onlinelibrary.wiley.com\/doi\/full\/10.1002\/mds.27832",
        "notes":"Novel, pathogenic alleles include expansions of TTTTAn + TTTCAn, but only the TTTCA is specific to affected individuals, check reference and pathogenic sites with Stranger. TTTCA within TTTTA repeat region",
        "details":null,
        "width":105.0,
        "OMIM":"601068",
        "Prevalence":null,
        "Prevalence_details":"FAME overall is 1\/35,000 in Japan",
        "STRipy_gene":"SAMD12",
        "gnomAD_gene":"SAMD12",
        "GeneReviews":"NBK535148",
        "Year":2018.0
    },
    {
        "chrom":"chrX",
        "start_hg38":140504316,
        "stop_hg38":140504361,
        "start_hg19":139586481,
        "stop_hg19":139586526,
        "start_t2t":138816205,
        "stop_t2t":138816239,
        "notes_t2t":"(GCGGCAGCGGCGGCGG)1.9",
        "id":"XLMR_SOX3",
        "disease_id":"XLMR",
        "gene_strand":"-",
        "reference_motif_reference_orientation":"NGC",
        "pathogenic_motif_reference_orientation":"NGC",
        "pathogenic_motif_gene_orientation":"CNG",
        "benign_motif_reference_orientation":null,
        "benign_motif_gene_orientation":"",
        "unknown_motif_reference_orientation":null,
        "unknown_motif_gene_orientation":"",
        "disease":"X-linked panhypopituitarism ; X-linked mental retardation with isolated growth hormone    ",
        "gene":"SOX3",
        "flank_motif":null,
        "locus_structure":"(NGC)*",
        "Inheritance":"XR",
        "type":"Coding",
        "location_in_gene":"Exon 1",
        "normal":"< 15",
        "normal_min":15.0,
        "normal_max":15.0,
        "intermediate":null,
        "intermediate_min":null,
        "intermediate_max":null,
        "pathogenic":"> 22",
        "pathogenic_min":22.0,
        "pathogenic_max":26.0,
        "ref_copies":15.0,
        "repeatunitlen":3,
        "age_onset":"Typical: 0-3 (PMID: 19654509, PMID: 21289259; small sample size); Range: 0-9 (PMID: 19654509) ",
        "age_onset_min":0,
        "age_onset_max":9,
        "typ_age_onset_min":null,
        "typ_age_onset_max":null,
        "novel":"ref",
        "Mechanism":"Polyalanine",
        "Mechanism_detail":"Polyalanine",
        "Mechanism_source":"(doi.org\/10.1007\/s11604-022-01343-5)",
        "source":"Pathogenic Short Tandem Repeats Gnomad v3.1.2, NBK535148",
        "notes":null,
        "details":null,
        "width":45.0,
        "OMIM":"300123",
        "Prevalence":null,
        "Prevalence_details":"3 families.",
        "STRipy_gene":"SOX3",
        "gnomAD_gene":"SOX3",
        "GeneReviews":"NBK535148",
        "Year":2002.0
    },
    {
        "chrom":"chr2",
        "start_hg38":96197067,
        "stop_hg38":96197121,
        "start_hg19":96862805,
        "stop_hg19":96862859,
        "start_t2t":96703675,
        "stop_t2t":96703729,
        "notes_t2t":"(AAAAT)11.6",
        "id":"FAME2_STARD7",
        "disease_id":"FAME2",
        "gene_strand":"-",
        "reference_motif_reference_orientation":"AAAAT",
        "pathogenic_motif_reference_orientation":"AAATG",
        "pathogenic_motif_gene_orientation":"ATTTC",
        "benign_motif_reference_orientation":null,
        "benign_motif_gene_orientation":"",
        "unknown_motif_reference_orientation":"AAAAA,AAAAC,AAACC,AAACG,AAACT,AACTC,AACTG,AATAC,AATAG,ATAAC",
        "unknown_motif_gene_orientation":"TTTTT,GTTTT,GGTTT,CGTTT,AGTTT,AGTTG,AGTTC,ATTGT,ATTCT,ATGTT",
        "disease":"Familial adult myoclonic epilepsy 2",
        "gene":"STARD7",
        "flank_motif":null,
        "locus_structure":"(AAATG)*(AAAAT)*",
        "Inheritance":"AD",
        "type":"Intronic",
        "location_in_gene":null,
        "normal":"0",
        "normal_min":0.0,
        "normal_max":0.0,
        "intermediate":null,
        "intermediate_min":null,
        "intermediate_max":null,
        "pathogenic":">274",
        "pathogenic_min":274.0,
        "pathogenic_max":274.0,
        "ref_copies":11.6,
        "repeatunitlen":5,
        "age_onset":"Typical: 12-30; Range: 4-60 (PMID: 31664034)",
        "age_onset_min":4,
        "age_onset_max":60,
        "typ_age_onset_min":12.0,
        "typ_age_onset_max":30.0,
        "novel":"novel",
        "Mechanism":"RNA toxicity",
        "Mechanism_detail":"RNA toxicity ",
        "Mechanism_source":"(10.1038\/s41467-019-12671-y)",
        "source":"Pathogenic Short Tandem Repeats Gnomad v3.1.2",
        "notes":null,
        "details":null,
        "width":54.0,
        "OMIM":"607876",
        "Prevalence":null,
        "Prevalence_details":"FAME overall is 1\/35,000 in Japan",
        "STRipy_gene":"STARD7",
        "gnomAD_gene":"STARD7",
        "GeneReviews":"NBK535148",
        "Year":2019.0
    },
    {
        "chrom":"chr6",
        "start_hg38":170561907,
        "stop_hg38":170562017,
        "start_hg19":170870995,
        "stop_hg19":170871105,
        "start_t2t":171935459,
        "stop_t2t":171935569,
        "notes_t2t":"(GCA)37.0",
        "id":"SCA17_TBP",
        "disease_id":"SCA17",
        "gene_strand":"+",
        "reference_motif_reference_orientation":"GCA",
        "pathogenic_motif_reference_orientation":"GCA",
        "pathogenic_motif_gene_orientation":"AGC",
        "benign_motif_reference_orientation":null,
        "benign_motif_gene_orientation":"",
        "unknown_motif_reference_orientation":null,
        "unknown_motif_gene_orientation":"",
        "disease":"Spinocerebellar ataxia type 17",
        "gene":"TBP",
        "flank_motif":null,
        "locus_structure":"(GCA)*",
        "Inheritance":"AD",
        "type":"Coding",
        "location_in_gene":"Exon 3",
        "normal":"25\u201340",
        "normal_min":25.0,
        "normal_max":40.0,
        "intermediate":"41\u201348",
        "intermediate_min":41.0,
        "intermediate_max":48.0,
        "pathogenic":"49 to 66",
        "pathogenic_min":49.0,
        "pathogenic_max":66.0,
        "ref_copies":37.0,
        "repeatunitlen":3,
        "age_onset":"Typical: 19-48; Range: 3-62 [has second variant to delay onset] (OMIM)",
        "age_onset_min":3,
        "age_onset_max":62,
        "typ_age_onset_min":19.0,
        "typ_age_onset_max":48.0,
        "novel":"ref",
        "Mechanism":"Polyglutamine ",
        "Mechanism_detail":"Polyglutamine ",
        "Mechanism_source":"(doi.org\/10.1038\/nrg.2017.115) (doi.org\/10.1007\/s11604-022-01343-5)",
        "source":"Hannan 2018, Mirkin 2007, GeneReviews NBK1438",
        "notes":"Parkinson disease,late-onset. Interruptions Seen: CAA (PMID: 35245110)",
        "details":null,
        "width":110.0,
        "OMIM":"607136",
        "Prevalence":"0.2\/100000",
        "Prevalence_details":"Unknown (global), <100 families, 0.47:1,000,000 (Japanese), 0.16\/100,000 (England) (GeneReview); Tang et al., 2017: 0.2\/100,000",
        "STRipy_gene":"TBP",
        "gnomAD_gene":"TBP",
        "GeneReviews":"NBK1438",
        "Year":1999.0
    },
    {
        "chrom":"chr22",
        "start_hg38":19766762,
        "stop_hg38":19766807,
        "start_hg19":19754285,
        "stop_hg19":19754330,
        "start_t2t":20143615,
        "stop_t2t":20143660,
        "notes_t2t":null,
        "id":"TOF_TBX1",
        "disease_id":"TOF",
        "gene_strand":"+",
        "reference_motif_reference_orientation":"GCN",
        "pathogenic_motif_reference_orientation":"GCN",
        "pathogenic_motif_gene_orientation":"CNG",
        "benign_motif_reference_orientation":null,
        "benign_motif_gene_orientation":"",
        "unknown_motif_reference_orientation":null,
        "unknown_motif_gene_orientation":"",
        "disease":"Tetralogy of Fallot",
        "gene":"TBX1",
        "flank_motif":null,
        "locus_structure":"(GCN)*",
        "Inheritance":"AD",
        "type":"Coding",
        "location_in_gene":null,
        "normal":"<15",
        "normal_min":15.0,
        "normal_max":15.0,
        "intermediate":null,
        "intermediate_min":null,
        "intermediate_max":null,
        "pathogenic":">25",
        "pathogenic_min":25.0,
        "pathogenic_max":25.0,
        "ref_copies":15.0,
        "repeatunitlen":3,
        "age_onset":"0",
        "age_onset_min":0,
        "age_onset_max":0,
        "typ_age_onset_min":null,
        "typ_age_onset_max":null,
        "novel":"ref",
        "Mechanism":"Polyalanine",
        "Mechanism_detail":"Polyalanine",
        "Mechanism_source":"(OMIM)",
        "source":"Pathogenic Short Tandem Repeats Gnomad v3.1.2, NBK535148",
        "notes":null,
        "details":null,
        "width":45.0,
        "OMIM":"187500",
        "Prevalence":null,
        "Prevalence_details":"1 individual with STR mutation (GeneReview)",
        "STRipy_gene":"TBX1",
        "gnomAD_gene":"TBX1",
        "GeneReviews":"NBK535148",
        "Year":null
    },
    {
        "chrom":"chr18",
        "start_hg38":55586155,
        "stop_hg38":55586227,
        "start_hg19":53253386,
        "stop_hg19":53253458,
        "start_t2t":55789234,
        "stop_t2t":55789288,
        "notes_t2t":"(AGC)18.3",
        "id":"FECD3_TCF4",
        "disease_id":"FECD3",
        "gene_strand":"-",
        "reference_motif_reference_orientation":"CAG",
        "pathogenic_motif_reference_orientation":"CAG",
        "pathogenic_motif_gene_orientation":"CTG",
        "benign_motif_reference_orientation":null,
        "benign_motif_gene_orientation":"",
        "unknown_motif_reference_orientation":null,
        "unknown_motif_gene_orientation":"",
        "disease":"Fuchs endothelial corneal dystrophy 3",
        "gene":"TCF4",
        "flank_motif":null,
        "locus_structure":"(CAG)*",
        "Inheritance":"AD",
        "type":"Intronic",
        "location_in_gene":"Intron 1",
        "normal":"10 - 40",
        "normal_min":10.0,
        "normal_max":40.0,
        "intermediate":null,
        "intermediate_min":null,
        "intermediate_max":null,
        "pathogenic":">50",
        "pathogenic_min":50.0,
        "pathogenic_max":150.0,
        "ref_copies":25.3,
        "repeatunitlen":3,
        "age_onset":"Typical: 40-59 (PMID: 1676829); Range: 32 (PMID: 21245398) - 70 (PMID: 25168903)",
        "age_onset_min":32,
        "age_onset_max":70,
        "typ_age_onset_min":40.0,
        "typ_age_onset_max":59.0,
        "novel":"ref",
        "Mechanism":"RNA toxicity proposed",
        "Mechanism_detail":"\"sequestration of MBNL1 in RNA foci, similar to the mechanism underlying myotonic dystrophy-1 \"",
        "Mechanism_source":"(10.1074\/jbc.M114.621607)",
        "source":"Pathogenic Short Tandem Repeats Gnomad v3.1.2, NBK535148",
        "notes":null,
        "details":"Penetrance is <100%; reduced penetrance has been reported in individuals with >80 CTG repeats [Wieben et al 2014]. Predominantly in women (~75%) (PMID: 16769829). \u201cAlthough studies on the prevalence of FECD worldwide are limited, the disorder is thought to be more common in Eurasian populations, with its corneal manifestations documented in 11% of females and 7% of males in Reykjavik, Iceland,3 8.5 % of Singapore Chinese,4 and 5.5% of Japanese.4 (PMID: 25722209)  ",
        "width":72.0,
        "OMIM":"613267",
        "Prevalence":"4.5\/100",
        "Prevalence_details":"~4\/100 (over 40) (OMIM); 5\/100 (PMID: 20825314)",
        "STRipy_gene":"TCF4",
        "gnomAD_gene":"TCF4",
        "GeneReviews":"NBK535148",
        "Year":2015.0
    },
    {
        "chrom":"chr16",
        "start_hg38":67842863,
        "stop_hg38":67842950,
        "start_hg19":67876766,
        "stop_hg19":67876853,
        "start_t2t":73638637,
        "stop_t2t":73638724,
        "notes_t2t":null,
        "id":"SCA_THAP11",
        "disease_id":"SCA",
        "gene_strand":"+",
        "reference_motif_reference_orientation":"CAG",
        "pathogenic_motif_reference_orientation":"CAG",
        "pathogenic_motif_gene_orientation":"AGC",
        "benign_motif_reference_orientation":null,
        "benign_motif_gene_orientation":"",
        "unknown_motif_reference_orientation":null,
        "unknown_motif_gene_orientation":"",
        "disease":"Spinocerebellar ataxia",
        "gene":"THAP11",
        "flank_motif":null,
        "locus_structure":"(CAG)*",
        "Inheritance":"AD",
        "type":"Coding",
        "location_in_gene":"Exon 1",
        "normal":"20-38",
        "normal_min":20.0,
        "normal_max":38.0,
        "intermediate":null,
        "intermediate_min":null,
        "intermediate_max":null,
        "pathogenic":"45-100",
        "pathogenic_min":45.0,
        "pathogenic_max":100.0,
        "ref_copies":29.3,
        "repeatunitlen":3,
        "age_onset":"Typical: 8-40 (small sample size); Range: 4-51 (PMID: 37148549)",
        "age_onset_min":4,
        "age_onset_max":51,
        "typ_age_onset_min":null,
        "typ_age_onset_max":null,
        "novel":"ref",
        "Mechanism":"PolyQ toxicity",
        "Mechanism_detail":null,
        "Mechanism_source":"https:\/\/doi.org\/10.1002\/mds.29412",
        "source":"https:\/\/doi.org\/10.1002\/mds.29412, https:\/\/doi.org\/10.1042\/ETLS20230018",
        "notes":"CAA interruptions can reduce toxicity (PMID: 37148549)",
        "details":"Expansion found in affected individuals from 2 families and not in 500 controls. Longer alleles were associated wither earlier age of onset. For example, an individual with 100 repeats had age of onset at 4 years.",
        "width":null,
        "OMIM":null,
        "Prevalence":null,
        "Prevalence_details":"Unknown",
        "STRipy_gene":null,
        "gnomAD_gene":null,
        "GeneReviews":null,
        "Year":2023.0
    },
    {
        "chrom":"chr16",
        "start_hg38":24613439,
        "stop_hg38":24613532,
        "start_hg19":24624760,
        "stop_hg19":24624853,
        "start_t2t":24890367,
        "stop_t2t":24890430,
        "notes_t2t":"(ATTTT)12.8",
        "id":"FAME6_TNRC6A",
        "disease_id":"FAME6",
        "gene_strand":"+",
        "reference_motif_reference_orientation":"TTTTA",
        "pathogenic_motif_reference_orientation":"TTTCA",
        "pathogenic_motif_gene_orientation":"ATTTC",
        "benign_motif_reference_orientation":null,
        "benign_motif_gene_orientation":"",
        "unknown_motif_reference_orientation":"TTTTT",
        "unknown_motif_gene_orientation":"TTTTT",
        "disease":"Familial adult myoclonic epilepsy type 6",
        "gene":"TNRC6A",
        "flank_motif":null,
        "locus_structure":"(TTTTA)*(TTTCA)*(TTTTA)*",
        "Inheritance":"AD",
        "type":"Intronic",
        "location_in_gene":null,
        "normal":"0",
        "normal_min":0.0,
        "normal_max":0.0,
        "intermediate":null,
        "intermediate_min":null,
        "intermediate_max":null,
        "pathogenic":">1100, >=10, 29",
        "pathogenic_min":1100.0,
        "pathogenic_max":1100.0,
        "ref_copies":18.8,
        "repeatunitlen":3,
        "age_onset":"Limited clinical details from one family, \"early 20s to 70s\"",
        "age_onset_min":23,
        "age_onset_max":74,
        "typ_age_onset_min":null,
        "typ_age_onset_max":null,
        "novel":"novel",
        "Mechanism":"RNA toxicity",
        "Mechanism_detail":"RNA toxicity hypothesized",
        "Mechanism_source":"(10.1038\/s41588-018-0067-2)",
        "source":"Ishiura 2018; gnomad v3.1.2, 29507423 (Pubmed), https:\/\/doi.org\/10.1038\/s41597-020-00633-9, https:\/\/stripy.org\/database\/TNRC6A",
        "notes":"Novel, reported pathogenic alleles: (TTTTA)22 (TTTCA)exp (TTTTA)exp, but only the TTTCA is specific to affected individuals, Alu-associated repeat. Non-pathogenic reference TTTTA repeat was expanded in nine healthy subjects 40-120 repeats and in two individuals potentially even longer (Ishiura et al., 2018).",
        "details":null,
        "width":93.0,
        "OMIM":"618074",
        "Prevalence":null,
        "Prevalence_details":"FAME overall is 1\/35,000 in Japan",
        "STRipy_gene":"TNRC6A",
        "gnomAD_gene":"TNRC6A",
        "GeneReviews":"NBK535148",
        "Year":2018.0
    },
    {
        "chrom":"chr1",
        "start_hg38":1435798,
        "stop_hg38":1435818,
        "start_hg19":1371178,
        "stop_hg19":1371198,
        "start_t2t":870158,
        "stop_t2t":870178,
        "notes_t2t":null,
        "id":"HMNR7_VWA1",
        "disease_id":"HMNR7",
        "gene_strand":"+",
        "reference_motif_reference_orientation":"GGCGCGGAGC",
        "pathogenic_motif_reference_orientation":"GGCGCGGAGC",
        "pathogenic_motif_gene_orientation":"AGCGGCGCGG",
        "benign_motif_reference_orientation":null,
        "benign_motif_gene_orientation":"",
        "unknown_motif_reference_orientation":null,
        "unknown_motif_gene_orientation":"",
        "disease":"Neuronopathy, distal hereditary motor, autosomal recessive 7",
        "gene":"VWA1",
        "flank_motif":null,
        "locus_structure":"(GGCGCGGAGC)*",
        "Inheritance":"AR",
        "type":"Coding",
        "location_in_gene":"Exon 1",
        "normal":"2",
        "normal_min":2.0,
        "normal_max":2.0,
        "intermediate":null,
        "intermediate_min":null,
        "intermediate_max":null,
        "pathogenic":"Any deviation from 2",
        "pathogenic_min":1.0,
        "pathogenic_max":3.0,
        "ref_copies":null,
        "repeatunitlen":10,
        "age_onset":"Typical: 1-3 (PMID: 33559681); Range: 0-10 (OMIM)",
        "age_onset_min":0,
        "age_onset_max":10,
        "typ_age_onset_min":1.0,
        "typ_age_onset_max":3.0,
        "novel":null,
        "Mechanism":"LoF",
        "Mechanism_detail":null,
        "Mechanism_source":"PMID: 38467784",
        "source":null,
        "notes":null,
        "details":"Any deviation from 2 motifs is thought to be pathogenic",
        "width":null,
        "OMIM":"619216",
        "Prevalence":null,
        "Prevalence_details":"Biallelic variants found in 0.01% of 100 KGP participants; enriched in those with motor disease. 80% of VWA1 pathogenic variants are expansions\/contractions (GeneReview)",
        "STRipy_gene":null,
        "gnomAD_gene":"VWA1",
        "GeneReviews":"NBK535148",
        "Year":null
    },
    {
        "chrom":"chr16",
        "start_hg38":17470907,
        "stop_hg38":17470922,
        "start_hg19":17564764,
        "stop_hg19":17564779,
        "start_t2t":17477910,
        "stop_t2t":17478013,
        "notes_t2t":"(GCC)34.7",
        "id":"DBQD2_XYLT1",
        "disease_id":"DBQD2, BSS",
        "gene_strand":"-",
        "reference_motif_reference_orientation":"GCC",
        "pathogenic_motif_reference_orientation":"GCC",
        "pathogenic_motif_gene_orientation":"CGG",
        "benign_motif_reference_orientation":null,
        "benign_motif_gene_orientation":"",
        "unknown_motif_reference_orientation":null,
        "unknown_motif_gene_orientation":"",
        "disease":"Baratela-Scott Syndrome\/Desbuquois dysplasia 2",
        "gene":"XYLT1",
        "flank_motif":null,
        "locus_structure":"(GCC)*",
        "Inheritance":"AR",
        "type":"Promoter",
        "location_in_gene":"Intron 1",
        "normal":"<20",
        "normal_min":0.0,
        "normal_max":20.0,
        "intermediate":null,
        "intermediate_min":null,
        "intermediate_max":null,
        "pathogenic":">72",
        "pathogenic_min":72.0,
        "pathogenic_max":110.0,
        "ref_copies":0.0,
        "repeatunitlen":3,
        "age_onset":"0 (birth)",
        "age_onset_min":0,
        "age_onset_max":0,
        "typ_age_onset_min":0.0,
        "typ_age_onset_max":0.0,
        "novel":"ref",
        "Mechanism":"Methylation",
        "Mechanism_detail":"Methylation",
        "Mechanism_source":"(doi.org\/10.1016\/j.ajhg.2018.11.005)",
        "source":"LaCroix 2019, gnomad v3.1.2, 30554721",
        "notes":"Repeat is within a sequencing missing from hg38",
        "details":null,
        "width":1.0,
        "OMIM":"615777",
        "Prevalence":null,
        "Prevalence_details":"<1 \/ 1,000,000 births (orphanet); \u00bd of DBQD variants (GeneReview). <50 DBQD cases",
        "STRipy_gene":"XYLT1",
        "gnomAD_gene":"XYLT1",
        "GeneReviews":"NBK535148",
        "Year":2019.0
    },
    {
        "chrom":"chr3",
        "start_hg38":183712188,
        "stop_hg38":183712222,
        "start_hg19":183429976,
        "stop_hg19":183430010,
        "start_t2t":186521657,
        "stop_t2t":186521706,
        "notes_t2t":"(ATTTT)10.0",
        "id":"FAME4_YEATS2",
        "disease_id":"FAME4",
        "gene_strand":"+",
        "reference_motif_reference_orientation":"TTTTA",
        "pathogenic_motif_reference_orientation":"TTTCA",
        "pathogenic_motif_gene_orientation":"ATTTC",
        "benign_motif_reference_orientation":null,
        "benign_motif_gene_orientation":"",
        "unknown_motif_reference_orientation":"TTTTT,TGTTA",
        "unknown_motif_gene_orientation":"TTTTT,ATGTT",
        "disease":"Familial adult myoclonic epilepsy 4",
        "gene":"YEATS2",
        "flank_motif":null,
        "locus_structure":"(TTTTA)*(TTTCA)*",
        "Inheritance":"AD",
        "type":"Intronic",
        "location_in_gene":null,
        "normal":"0",
        "normal_min":0.0,
        "normal_max":0.0,
        "intermediate":null,
        "intermediate_min":null,
        "intermediate_max":null,
        "pathogenic":">1000",
        "pathogenic_min":1000.0,
        "pathogenic_max":1000.0,
        "ref_copies":10.0,
        "repeatunitlen":5,
        "age_onset":"Typical: 20-25 (PMID: 22713812); Range: 10-33 (PMID: 31539032)",
        "age_onset_min":10,
        "age_onset_max":33,
        "typ_age_onset_min":null,
        "typ_age_onset_max":null,
        "novel":"novel",
        "Mechanism":"RNA toxicity",
        "Mechanism_detail":"RNA toxicity hypothesized",
        "Mechanism_source":"(10.1093\/brain\/awz267)",
        "source":"Pathogenic Short Tandem Repeats Gnomad v3.1.2",
        "notes":null,
        "details":null,
        "width":34.0,
        "OMIM":"615127",
        "Prevalence":null,
        "Prevalence_details":"FAME overall is 1\/35,000 in Japan",
        "STRipy_gene":"YEATS2",
        "gnomAD_gene":"YEATS2",
        "GeneReviews":"NBK535148",
        "Year":2019.0
    },
    {
        "chrom":"chr16",
        "start_hg38":72787695,
        "stop_hg38":72787758,
        "start_hg19":72821594,
        "stop_hg19":72821657,
        "start_t2t":78605503,
        "stop_t2t":78605569,
        "notes_t2t":"(GCC)22.3",
        "id":"SCA4_ZFHX3",
        "disease_id":"SCA4",
        "gene_strand":"-",
        "reference_motif_reference_orientation":"GCC",
        "pathogenic_motif_reference_orientation":"GCC",
        "pathogenic_motif_gene_orientation":"CGG",
        "benign_motif_reference_orientation":null,
        "benign_motif_gene_orientation":"",
        "unknown_motif_reference_orientation":null,
        "unknown_motif_gene_orientation":"",
        "disease":"Spinocerebellar ataxia 4",
        "gene":"ZFHX3",
        "flank_motif":null,
        "locus_structure":"(GCC)*",
        "Inheritance":"AD",
        "type":"Coding",
        "location_in_gene":"Last Exon",
        "normal":"16-26 (majority 21)",
        "normal_min":16.0,
        "normal_max":26.0,
        "intermediate":null,
        "intermediate_min":null,
        "intermediate_max":null,
        "pathogenic":"46-64",
        "pathogenic_min":46.0,
        "pathogenic_max":64.0,
        "ref_copies":21.3,
        "repeatunitlen":3,
        "age_onset":"Typical: 37- 56; Range: 15 - 60 (PMID: 38035881 - https:\/\/doi.org\/10.1101\/2023.10.03.23296230) ",
        "age_onset_min":15,
        "age_onset_max":60,
        "typ_age_onset_min":37.0,
        "typ_age_onset_max":56.0,
        "novel":"ref",
        "Mechanism":null,
        "Mechanism_detail":null,
        "Mechanism_source":null,
        "source":"https:\/\/doi.org\/10.1101\/2023.10.03.23296230",
        "notes":null,
        "details":"Expansion found in affected individuals from 3 families and not in any of the 1001 controls. Possible anticipation (PMID: 38197134, PMID: 38035881)",
        "width":null,
        "OMIM":"600223",
        "Prevalence":null,
        "Prevalence_details":"Unknown",
        "STRipy_gene":null,
        "gnomAD_gene":null,
        "GeneReviews":null,
        "Year":2023.0
    },
    {
        "chrom":"chr13",
        "start_hg38":99985448,
        "stop_hg38":99985493,
        "start_hg19":100637702,
        "stop_hg19":100637747,
        "start_t2t":99196359,
        "stop_t2t":99196404,
        "notes_t2t":"(GCG)15.3",
        "id":"HPE5_ZIC2",
        "disease_id":"HPE5",
        "gene_strand":"+",
        "reference_motif_reference_orientation":"GCN",
        "pathogenic_motif_reference_orientation":"GCN",
        "pathogenic_motif_gene_orientation":"CNG",
        "benign_motif_reference_orientation":null,
        "benign_motif_gene_orientation":"",
        "unknown_motif_reference_orientation":null,
        "unknown_motif_gene_orientation":"",
        "disease":"Holoprosencephaly-5",
        "gene":"ZIC2",
        "flank_motif":null,
        "locus_structure":"(GCN)*",
        "Inheritance":"AD",
        "type":"Coding",
        "location_in_gene":"Exon 3",
        "normal":"< 15",
        "normal_min":15.0,
        "normal_max":15.0,
        "intermediate":null,
        "intermediate_min":null,
        "intermediate_max":null,
        "pathogenic":">25",
        "pathogenic_min":25.0,
        "pathogenic_max":25.0,
        "ref_copies":15.3,
        "repeatunitlen":3,
        "age_onset":"0",
        "age_onset_min":0,
        "age_onset_max":0,
        "typ_age_onset_min":0.0,
        "typ_age_onset_max":0.0,
        "novel":"ref",
        "Mechanism":"Polyalanine ",
        "Mechanism_detail":"Polyalanine ",
        "Mechanism_source":"(doi.org\/10.1038\/nature05977) (doi.org\/10.1007\/s11604-022-01343-5)",
        "source":"Pathogenic Short Tandem Repeats Gnomad v3.1.2, NBK535148",
        "notes":null,
        "details":null,
        "width":45.0,
        "OMIM":"609637",
        "Prevalence":"1.4\/1000000",
        "Prevalence_details":"0.05-0.23\/100,000; math done by 40% of pathogenic variants in ZIC2 are expansion (GeneReview); 5% of non-syndromic HPE are ZIC2 gene (NBK1530), and nonsyndromic HPE is [25]-50% of HPE, which affects 1\/10,000 newborns (Medline non-syndromic HPE) - ZIC2 is 9.2% of HPE cases, whicho ccur in 1\/16,000 live births (PMID: 17274816)",
        "STRipy_gene":"ZIC2",
        "gnomAD_gene":"ZIC2",
        "GeneReviews":"NBK1530",
        "Year":2001.0
    },
    {
        "chrom":"chrX",
        "start_hg38":137566826,
        "stop_hg38":137566856,
        "start_hg19":136648985,
        "stop_hg19":136649015,
        "start_t2t":135876774,
        "stop_t2t":135876800,
        "notes_t2t":"(CGC)9.0",
        "id":"VACTERLX_ZIC3",
        "disease_id":"VACTERLX",
        "gene_strand":"+",
        "reference_motif_reference_orientation":"GCN",
        "pathogenic_motif_reference_orientation":"GCN",
        "pathogenic_motif_gene_orientation":"CNG",
        "benign_motif_reference_orientation":null,
        "benign_motif_gene_orientation":"",
        "unknown_motif_reference_orientation":null,
        "unknown_motif_gene_orientation":"",
        "disease":"X-linked VACTERL syndrome",
        "gene":"ZIC3",
        "flank_motif":null,
        "locus_structure":"(GCN)*",
        "Inheritance":"XR",
        "type":"Coding",
        "location_in_gene":null,
        "normal":"<10",
        "normal_min":9.0,
        "normal_max":10.0,
        "intermediate":"11",
        "intermediate_min":11.0,
        "intermediate_max":11.0,
        "pathogenic":">12",
        "pathogenic_min":12.0,
        "pathogenic_max":12.0,
        "ref_copies":9.0,
        "repeatunitlen":3,
        "age_onset":"0",
        "age_onset_min":0,
        "age_onset_max":0,
        "typ_age_onset_min":null,
        "typ_age_onset_max":null,
        "novel":"ref",
        "Mechanism":"Polyalanine",
        "Mechanism_detail":"Polyalanine",
        "Mechanism_source":"(doi.org\/10.1038\/nature05977)",
        "source":"Pathogenic Short Tandem Repeats Gnomad v3.1.2, NBK535148",
        "notes":null,
        "details":null,
        "width":30.0,
        "OMIM":"314390",
        "Prevalence":null,
        "Prevalence_details":"1 patient with VACTERL died at birth. 8 patients with X-linked OAVS at 11 motifs; 1 individual in OAVS cohort with 12 repeats. ",
        "STRipy_gene":"ZIC3",
        "gnomAD_gene":"ZIC3",
        "GeneReviews":"NBK535148",
        "Year":null
    },
    {
        "chrom":"chr7",
        "start_hg38":55887601,
        "stop_hg38":55887639,
        "start_hg19":55955294,
        "stop_hg19":55955332,
        "start_t2t":56047901,
        "stop_t2t":56047939,
        "notes_t2t":"(GCG)15.0",
        "id":"FRA7A_ZNF713",
        "disease_id":"FRA7A",
        "gene_strand":"+",
        "reference_motif_reference_orientation":"GCG",
        "pathogenic_motif_reference_orientation":"GCG",
        "pathogenic_motif_gene_orientation":"CGG",
        "benign_motif_reference_orientation":null,
        "benign_motif_gene_orientation":"",
        "unknown_motif_reference_orientation":null,
        "unknown_motif_gene_orientation":"",
        "disease":"Autism spectrum disorder associated with fragile site FRA7A",
        "gene":"ZNF713",
        "flank_motif":null,
        "locus_structure":"(GCG)*",
        "Inheritance":"AD",
        "type":"Intronic",
        "location_in_gene":null,
        "normal":"5-22",
        "normal_min":5.0,
        "normal_max":22.0,
        "intermediate":"85",
        "intermediate_min":85.0,
        "intermediate_max":85.0,
        "pathogenic":"450",
        "pathogenic_min":450.0,
        "pathogenic_max":450.0,
        "ref_copies":13.0,
        "repeatunitlen":3,
        "age_onset":"2-3 (four individuals; PMID: 25196122)",
        "age_onset_min":2,
        "age_onset_max":3,
        "typ_age_onset_min":null,
        "typ_age_onset_max":null,
        "novel":"ref",
        "Mechanism":"Methylation",
        "Mechanism_detail":"Methylation",
        "Mechanism_source":"(OMIM)",
        "source":"OMIM, https:\/\/pubmed.ncbi.nlm.nih.gov\/25196122\/",
        "notes":null,
        "details":null,
        "width":38.0,
        "OMIM":"616181",
        "Prevalence":null,
        "Prevalence_details":"4 individuals",
        "STRipy_gene":null,
        "gnomAD_gene":null,
        "GeneReviews":null,
        "Year":null
    }
]